Second line medication for Crohn's disease

RX_CROHN_2NDLINE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — L04AX\|L01BB02 1 out of 7 registries used, show all original rules.	34928
4. Check minimum number of events Min. number of events 3	34928
5. Include endpoints None	34928
6. Filter based on genotype QC (FinnGen only)	31455

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	RX_CROHN_2NDLINE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	L04AX\|L01BB02
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Second line medication for Crohn's disease based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	143874	84541	58823
Only index persons	136668	80893	55775
Unadjusted period prevalence (%)
Whole population	2.10	2.42	1.64
Only index persons	2.63	2.97	2.13
Median age at first event (years)
Whole population	53.34	53.97	52.43
Only index persons	53.04	53.70	52.07

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	31455	19470	11985
Unadjusted period prevalence (%)	6.37	6.91	5.50
Median age at first event (years)	53.60	52.36	55.60

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
32445: Matched controls
324000

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

25.9

320.9

222

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

318.2

3465

17609

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

5.2

317.9

668

1313

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

6.9

314.9

489

717

9522

FHL

Synovectomy

25.1

309.8

217

L01CB

ATC

Podophyllotoxin derivatives

30.4

309.6

203

R4180

NOMESCO Finland

Podiatric therapy

5.5

309.5

608

1125

L04AF03

ATC

upadacitinib; oral

59.4

307.7

365

256, ,

Kela drug reimbursment

60.3

307.7

376

L04AA32

ATC

apremilast; oral

31.5

307.7

346

111

NH3AE

NOMESCO Finland

Feet ultrasound examination

22.1

307.7

299

136

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

20.9

307.7

1024

504

L04AB01

ATC

etanercept; parenteral

57.5

307.7

2644

499

L04AA37

ATC

[U] baricitinib

73.5

307.7

270

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

5.3

307.7

4332

9165

M13.8

ICD-10 Finland

Other specified arthritis

7.8

307.7

650

852

NDG30

NOMESCO Finland

Fusion of wrist, total

20.0

307.7

468

237

K50.0

ICD-10 Finland

Crohn disease of small intestine

21.1

307.7

1817

908

L04AX01

ATC

azathioprine; systemic

114.3

307.7

9043

1092

G35

ICD-10 Finland

Multiple sclerosis

5.0

307.7

836

1689

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

13.5

307.7

405

302

XX9XE

NOMESCO Finland

Other ultrasound examination

18.4

307.7

876

488

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.0

307.7

1570

5480

P01BA02

ATC

hydroxychloroquine; oral

28.6

307.7

12278

6749

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.8

307.7

865

1833

J01DB01

ATC

cefalexin; oral

1.9

307.7

27125

236238

M05BA07

ATC

risedronic acid; oral

3.9

307.7

1155

3064

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

6.9

307.7

1061

1580

H20.1

ICD-10 Finland

Chronic iridocyclitis

9.0

307.7

751

850

253, ,

Kela drug reimbursment

42.3

307.7

422

101

M07.3

ICD-10 Finland

Other psoriatic arthropathies

48.6

307.7

1460

314

L04AA24

ATC

abatacept; parenteral

79.5

307.7

678

D07XC01

ATC

betamethasone; topical

2.8

307.7

5106

20108

K50.1

ICD-10 Finland

Crohn disease of large intestine

24.9

307.7

1492

625

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

39.6

307.7

1336

351

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

52.2

307.7

280

M25.5

ICD-10 Finland

Pain in joint

2.0

307.7

12443

77949

E000001, ,

ATC

1.8

307.7

6532

39828

ZX140

NOMESCO Finland

Intra articular

14.4

307.7

633

447

291

Kela drug reimbursment

Tofacitinib

84.0

307.7

374

L04AC18

ATC

risankizumab; parenteral

53.9

307.7

326

L01BB01, ,

ATC

178.2

307.7

283

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

6.9

307.7

811

1197

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.3

307.7

1039

2007

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

7.2

307.7

507

711

NDL52

NOMESCO Finland

Tenosynovectomy of hand

13.6

307.7

546

406

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

24.1

307.7

891

379

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

6.0

307.7

765

1306

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.2

307.7

1388

4459

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

307.7

3339

16541

L04AB04

ATC

adalimumab; parenteral

68.0

307.7

4153

698

153

Kela drug reimbursment

Lenalidomid

95.1

307.7

726

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.6

307.7

1035

2287

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

30.6

307.7

1084

365

K75.4

ICD-10 Finland

Autoimmune hepatitis

24.0

307.7

248

104

4AB02, ,

NOMESCO Finland

123.0

307.7

521

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.4

307.7

20204

106233

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

42.8

307.7

4054

1078

M01CB03

ATC

auranofin; oral

24.0

307.7

700

298

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

7.0

307.7

984

1443

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

39.8

307.7

3258

907

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

11.9

307.7

923

792

134

Kela drug reimbursment

General erythroderma

18.6

307.7

290

157

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

307.7

14241

106313

L04AK01

ATC

leflunomide; oral

39.5

307.7

890

231

RT272, ,

NOMESCO Finland

21.8

307.7

310

143

WZC30

NOMESCO Finland

Teaching

1.9

307.7

5640

32303

L04AA29

ATC

[U] tofacitinib

67.4

307.7

433

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

17.5

307.7

794

465

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

40.7

307.7

769

193

A07EA02

ATC

hydrocortisone; rectal

10.2

307.7

1815

1868

D07AD01

ATC

clobetasol; topical

2.2

307.7

6430

33164

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

22.6

307.7

443

198

RT271, ,

NOMESCO Finland

27.8

307.7

224

E0000UV, ,

ATC

1.8

307.7

14783

101009

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

27.3

307.7

303

112

L04AC14

ATC

sarilumab; systemic

92.8

307.7

249

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.9

307.7

3920

14568

3006

Kela drug reimbursment

Baricitinib

70.1

307.7

306

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

14.7

307.7

696

484

D05AX03

ATC

calcitriol; topical

8.0

307.7

826

1049

UJF92

NOMESCO Finland

Capsular endoscopy

4.8

307.7

1180

2512

M01AC06

ATC

meloxicam; systemic, rectal

1.7

307.7

11416

80168

329

Kela drug reimbursment

Lenalidomide

97.9

307.7

559

356

Kela drug reimbursment

Nintedanib and pirfenidone

20.7

307.7

382

186

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

52.0

307.7

3102

657

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.8

307.7

17804

65842

D05BB02

ATC

acitretin; oral

7.5

307.7

1577

2186

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

75.4

307.7

1360

188

K50

ICD-10 Finland

Crohn disease [regional enteritis]

23.4

307.7

430

186

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.1

307.7

1445

4808

D94

ICPC

Chronic enteritis/ulcerative colitis

11.4

307.7

644

576

M35.1

ICD-10 Finland

Other overlap syndromes

15.3

307.7

367

242

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

23.0

307.7

354

155

M45

ICD-10 Finland

Ankylosing spondylitis

10.3

307.7

1783

1819

M01CB01

ATC

sodium aurothiomalate; parenteral

37.2

307.7

1619

457

D07AC13

ATC

mometasone; topical

1.7

307.7

9219

62604

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

65.2

307.7

9140

1936

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

54.7

307.7

581

108

L04AX07

ATC

dimethyl fumarate; oral

216.5

307.7

575

A02BC02

ATC

pantoprazole; systemic

2.2

307.7

23780

178145

L40

ICD-10 Finland

Psoriasis

5.1

307.7

1053

2113

127

Kela drug reimbursment

Transplant complication

5.3

307.7

861

1655

L04AX04

ATC

lenalidomide; oral

147.0

307.7

734

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.1

307.7

2681

9087

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

25.5

307.7

604

241

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

307.7

4658

23242

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

10.3

307.7

1073

1077

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

8.0

307.7

688

872

L88

ICPC

Rheumatoid/seropositive arthritis

52.7

307.7

7372

1796

4AA12, ,

NOMESCO Finland

111.2

307.7

461

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

12.2

307.7

650

544

L04AX05

ATC

pirfenidone; oral

183.8

307.7

382

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

44.1

307.7

354

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

34.9

307.7

349

101

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

9.2

307.7

1985

2279

M13.0

ICD-10 Finland

Polyarthritis, unspecified

11.0

307.7

963

898

L04AA13

ATC

[U] leflunomide

52.0

307.7

3913

853

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

10.0

307.7

514

523

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

8.7

307.7

675

790

J01MA02

ATC

ciprofloxacin; systemic

1.6

307.7

11852

85270

H26.3

ICD-10 Finland

Drug-induced cataract

10.0

307.7

415

421

L04AC05

ATC

ustekinumab; parenteral

55.5

307.7

786

145

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

29.8

307.7

372

126

N07XX09

ATC

[U] dimethyl fumarate

40.1

307.7

271

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

307.7

9906

60719

TGC00

NOMESCO Finland

Bronchial lavation

3.8

307.7

1072

2857

NF1AA

NOMESCO Finland

Hip X-ray examination

2.3

307.7

3019

14083

H02AB06

ATC

prednisolone; systemic

7.1

307.7

25217

107006

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

307.7

7590

44581

L04AC07

ATC

tocilizumab; parenteral

59.2

307.7

496

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

64.9

307.7

20115

7940

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

15.0

307.7

1766

1236

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

13.6

307.7

695

520

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.2

307.7

2272

4603

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

42.4

307.7

964

234

M13.9

ICD-10 Finland

Arthritis, unspecified

8.5

307.7

6710

9620

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

21.9

307.7

592

275

WZA10

NOMESCO Finland

Extensive medical or dental certificate

10.4

307.7

1154

1141

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

5.8

307.7

707

1249

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

15.1

307.7

690

466

M01AH05

ATC

etoricoxib; oral

1.6

307.7

20363

166080

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

37.0

307.7

1713

488

TNG10

NOMESCO Finland

Puncture of knee

22.0

307.7

1254

592

L04AF01

ATC

tofacitinib; oral

105.4

307.7

168

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

6.6

307.7

870

1345

M06

ICD-10 Finland

Other rheumatoid arthritis

44.1

307.7

764

177

H02AB04

ATC

methylprednisolone; systemic

2.4

307.7

5697

25922

N02AX02

ATC

tramadol; systemic, rectal

1.7

307.7

14061

99513

D05AX02

ATC

calcipotriol; topical

5.8

307.7

2239

4108

L40.8

ICD-10 Finland

Other psoriasis

7.5

307.7

487

654

C90.0

ICD-10 Finland

Multiple myeloma

15.0

307.7

800

546

H02AB07

ATC

prednisone; oral

4.1

307.7

7310

21696

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

7.9

307.7

1879

2515

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

4.0

307.7

1926

5063

L40.0

ICD-10 Finland

Psoriasis vulgaris

7.4

307.7

3373

4988

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

67.4

307.7

1859

292

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

8.7

307.7

1454

1736

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

12.6

307.7

1719

1430

TQW80

NOMESCO Finland

Local dermatologic skincare

4.0

307.7

1234

3181

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

14.0

307.7

446

323

NH3EA

NOMESCO Finland

Feet X-ray examination with load

12.8

307.7

1883

1558

L04AA44

ATC

[U] upadacitinib

73.2

307.7

240

L40.5

ICD-10 Finland

Arthropathic psoriasis

38.1

307.7

2450

693

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

15.8

307.7

5633

4242

XW000

NOMESCO Finland

Bone marrow biopsy

3.0

307.7

1493

5095

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.6

307.7

923

2050

L04AX03

ATC

methotrexate; systemic

358.1

307.7

23943

2528

S91

ICPC

Psoriasis

9.3

307.7

662

725

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

34.2

307.7

238

K51

ICD-10 Finland

Ulcerative colitis

10.1

307.7

814

823

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

21.9

307.7

382

176

L04AB02

ATC

infliximab; parenteral

75.9

307.7

823

111

L01BA01

ATC

methotrexate; systemic

70.0

307.7

6499

1156

K50.8

ICD-10 Finland

Other Crohn disease

27.4

307.7

2045

793

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

307.7

14297

102049

L04AD01

ATC

ciclosporin; systemic

15.8

307.7

1946

1304

L04AC10

ATC

secukinumab; parenteral

34.9

307.7

594

173

K51.8

ICD-10 Finland

Other ulcerative colitis

12.8

307.7

1289

1041

3029

Kela drug reimbursment

Upadacitinib

64.4

307.7

420

M05BA04

ATC

alendronic acid; oral

3.9

307.7

3938

11217

D05AX52

ATC

calcipotriol, combinations; topical

5.6

307.7

3614

7062

K50.9

ICD-10 Finland

Crohn disease, unspecified

20.2

307.7

1737

906

M31.3

ICD-10 Finland

Wegener granulomatosis

27.3

307.7

327

121

L04AA06

ATC

mycophenolic acid; systemic

6.7

307.7

1324

2035

UJF30

NOMESCO Finland

Ileoscopy through colon

3.5

307.7

5506

18009

L04AA01

ATC

[U] ciclosporin

22.1

307.7

1536

727

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

69.0

307.7

5345

923

K51.5

ICD-10 Finland

Left sided colitis

14.9

307.7

3064

2252

3042, ,

Kela drug reimbursment

41.8

307.7

422

102

284

Kela drug reimbursment

Nintedanib and pirfenidone

21.8

307.7

388

180

3005

Kela drug reimbursment

Tofacitinib

69.3

307.7

425

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

22.5

307.7

9313

5699

109

Kela drug reimbursment

Multiple sclerosis

7.2

307.7

741

1047

D07AC01

ATC

betamethasone; topical

1.8

307.7

12524

83669

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

5.6

307.7

861

1573

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

25.8

307.7

10199

5658

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

307.7

3732

16227

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.7

307.7

2402

6870

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

54.5

307.7

626

117

NG1DA

NOMESCO Finland

X-ray of knees

5.8

307.7

1018

1794

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

12.6

307.7

1867

1563

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

6.2

307.7

7448

14968

J01FF01

ATC

clindamycin; systemic

1.7

307.7

8727

58326

WW200

NOMESCO Finland

Immunization

3.5

307.7

1183

3482

L01BB02

ATC

mercaptopurine; oral

66.6

307.7

2044

327

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.8

307.7

5990

14581

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

34.8

307.7

345

100

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

21.9

307.7

569

264

A07EC01

ATC

sulfasalazine; oral, rectal

31.2

307.7

12341

6244

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

307.7

7600

48370

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

68.9

307.7

5657

990

298, ,

Kela drug reimbursment

70.4

307.7

404

L04AA17

ATC

[U] adalimumab

53.7

307.7

404

ZX120

NOMESCO Finland

Intravenous

4.1

307.7

5052

13978

L04AB06

ATC

golimumab; parenteral

55.9

307.7

1312

244

L04AA33

ATC

[U] vedolizumab

45.1

307.7

260

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

21.0

307.7

354

170

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

10.7

307.7

2940

2998

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

8.2

307.7

785

980

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

10.2

307.7

533

528

L04AG05

ATC

vedolizumab; parenteral

42.4

307.7

349

A07EA06

ATC

budesonide; oral, local oral

12.0

307.7

4074

3840

R4110

NOMESCO Finland

Physiotherapy

1.7

307.7

8838

59535

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

307.7

4878

25795

M01AH01

ATC

celecoxib; oral

1.9

307.7

5988

33910

H02AB09

ATC

hydrocortisone; systemic

4.5

307.7

1246

2822

L04AB05

ATC

certolizumab pegol; parenteral

53.5

307.7

703

134

L40.9

ICD-10 Finland

Psoriasis, unspecified

5.3

307.7

893

1713

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

41.5

307.7

624

153

L20

ICPC

Joint symptom/complaint NOS

3.3

307.7

1820

5760

A07EC02

ATC

mesalazine; oral, rectal

9.6

307.7

5118

6170

UJF32

NOMESCO Finland

Coloscopy

2.4

307.7

10218

52366

L04AA11

ATC

[U] etanercept

49.3

307.7

462

R4120

NOMESCO Finland

Occupational therapy

3.0

307.7

2874

10041

293

Kela drug reimbursment

Baricitinib

77.0

307.7

283

M35.3

ICD-10 Finland

Polymyalgia rheumatica

4.2

307.7

1887

4689

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

35.8

307.7

4443

1430

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

8.4

307.7

887

1084

R50.9

ICD-10 Finland

Fever, unspecified

2.1

307.7

5542

29335

L04AC13

ATC

ixekizumab; parenteral

49.1

307.7

451

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

307.7

13391

97764

L04AC16

ATC

guselkumab; systemic

52.0

307.7

279

M05BX04

ATC

denosumab; parenteral

2.5

306.8

2082

8683

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

304.4

5844

35740

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

11.1

301.1

319

289

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.3

298.2

2573

11919

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

298.1

2910

14166

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.5

294.9

1921

7855

9256

FHL

Synovectomy (knee 9311)

29.2

293.6

195

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

291.1

1702

6601

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

11.3

289.9

303

269

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.5

288.3

1028

3008

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

21.1

288.0

216

103

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.8

285.2

1481

5402

Z3231

NOMESCO Finland

Registered nurse

1.6

285.2

8380

57254

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

36.8

283.7

176

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

283.3

2686

12917

J05AB11

ATC

valaciclovir; oral

1.8

283.1

4827

28440

299, ,

Kela drug reimbursment

57.0

282.7

159

N02BE01

ATC

paracetamol; systemic, rectal

1.9

281.7

28695

259954

ND1AE

NOMESCO Finland

Wrist ultrasound examination

12.9

280.8

270

210

H02AB08

ATC

triamcinolone; systemic

13.6

280.6

262

194

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

279.1

2701

13090

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.9

278.9

845

2214

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

275.7

13747

105643

Z3226

NOMESCO Finland

Physiotherapist

1.7

275.5

5580

34540

M07.0

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

33.8

275.4

175

J05AB01

ATC

aciclovir; systemic

1.7

275.0

7014

46186

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

272.4

7041

46503

9503

FHL

Tendon or tendon sheath cleansing surgery (tenosynovectomy)

16.3

271.2

229

141

L04AC21

ATC

bimekizumab; systemic

51.8

270.6

155

Z94.0

ICD-10 Finland

Kidney transplant status

5.2

268.7

561

1096

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

5.4

267.1

533

1000

M34.1

ICD-10 Finland

CR(E)ST syndrome

11.2

267.0

281

252

D07AB08

ATC

desonide; topical

1.9

261.6

3547

19395

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

259.4

2530

12285

1XC02, ,

NOMESCO Finland

7.7

255.8

360

473

C10AC01

ATC

colestyramine; oral

3.1

254.7

1103

3634

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

16.7

249.3

208

125

WX002

NOMESCO Finland

Sedation and analgesia

1.7

249.1

5668

36109

M12.3

ICD-10 Finland

Palindromic rheumatism

15.3

247.1

216

142

NDF10

NOMESCO Finland

Synovectomy of wrist

25.4

246.7

172

4AA33, ,

NOMESCO Finland

52.4

246.6

141

7151

FHL

Kidney transplantation

106.1

246.4

127

M06.3

ICD-10 Finland

Rheumatoid nodule

45.4

246.2

145

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

14.2

244.9

223

158

A02BC03

ATC

lansoprazole; oral

1.6

243.7

8363

58866

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

5.3

243.5

499

959

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

14.9

242.6

215

145

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

242.4

9542

69218

318

Kela drug reimbursment

Teriparatide

8.9

239.0

298

338

RK220, ,

NOMESCO Finland

11.7

236.5

242

208

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

5.7

233.0

441

788

RT310, ,

NOMESCO Finland

41.3

232.4

140

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

30.9

231.4

151

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

231.3

3823

22206

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

229.9

1244

4630

J01MA12

ATC

levofloxacin; systemic

1.7

228.3

5312

33956

S18

ICPC

Laceration/cut

1.5

228.3

14333

113874

WW300

NOMESCO Finland

Transfer of autologic stem cells

10.4

227.0

251

242

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.5

226.1

1453

5889

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

225.6

9067

65848

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

225.5

3965

23449

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

39.3

224.5

137

B01AB05

ATC

enoxaparin; parenteral

1.5

223.9

9203

67132

A04AA01

ATC

ondansetron; systemic, rectal

2.0

223.4

2734

14399

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

223.4

2060

9767

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

37.4

223.4

138

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

6.0

222.6

396

667

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

6.8

222.1

347

512

M17.5

ICD-10 Finland

Other secondary gonarthrosis

4.2

221.5

595

1427

H05AA02

ATC

teriparatide; parenteral

8.9

221.0

275

311

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

11.2

220.7

233

210

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

220.4

3417

19445

Z2221

NOMESCO Finland

Medical doctor

1.5

219.5

8191

58484

M81.4

ICD-10 Finland

Drug-induced osteoporosis

8.9

219.5

272

306

PAW37

NOMESCO Finland

Biopsy of temporal artery

7.3

219.2

324

450

9284

FHL

Wrist ossification surgery

31.6

219.2

142

D02AE01

ATC

carbamide; topical

2.2

219.2

2080

9972

L99

ICPC

Musculoskeletal disease other

3.2

218.6

888

2815

393

Kela drug reimbursment

Pomalidomide

719.1

218.0

215

B03XA01

ATC

erythropoietin; parenteral

6.3

217.6

365

580

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

10.4

217.3

240

231

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.6

216.4

745

2128

L04AF02

ATC

baricitinib; oral

87.9

216.4

114

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

4.9

215.3

480

992

7143C

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]

28.3

214.5

144

NDF60

NOMESCO Finland

Operation for osteochondritis of a joint of hand,v

11.6

214.3

220

190

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.1

213.7

929

3065

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

19.8

213.0

164

NDB60

NOMESCO Finland

Prosthetic replacement of MCP joint of finger

23.1

213.0

154

ZXE00

NOMESCO Finland

One hour or less

1.5

212.5

11464

88093

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

15.7

212.5

183

117

NCF10

NOMESCO Finland

Synovectomy of elbow joint, open

31.9

212.1

137

L04AX06

ATC

pomalidomide; oral

1039.2

211.5

207

A07EA01

ATC

prednisolone; oral, rectal

7.6

211.0

298

393

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

17.8

210.0

170

L04AD02

ATC

tacrolimus; systemic

4.6

208.8

506

1120

M33.2

ICD-10 Finland

Polymyositis

19.0

207.8

163

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.2

206.6

862

2776

1507

Kela drug reimbursment

Pomalidomide

681.9

206.5

204

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

205.6

1207

4679

L34

ICPC

Musculoskeletal, Blood test

44.9

204.8

121

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.7

204.6

482

1043

JF1BD

NOMESCO Finland

Very extensive small bowel CT

7.4

204.3

297

405

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

204.1

11657

90360

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

6.8

202.0

317

470

P01BA01

ATC

chloroquine; systemic

8.8

200.9

252

288

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

200.9

3002

16862

JF1AD

NOMESCO Finland

Small bowel CT

5.9

200.8

360

611

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

4.6

199.6

474

1032

P01AB01

ATC

metronidazole; oral, rectal

1.4

199.2

12202

95696

A02BC01

ATC

omeprazole; systemic

1.5

198.2

7798

56093

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

197.6

10175

77215

ZX112

NOMESCO Finland

Subcutaneous

3.3

197.4

772

2391

XPX04

NOMESCO Finland

Angioscopy

8.3

196.9

259

314

E000003, ,

ATC

2.4

196.6

1444

6215

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

6.9

196.0

305

448

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

18.4

196.0

156

M08.8

ICD-10 Finland

Other juvenile arthritis

60.7

195.8

109

M01CC01

ATC

penicillamine; oral

21.7

195.8

145

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

32.1

193.8

125

L01AA03

ATC

melphalan; systemic

27.0

193.5

132

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

193.5

2182

11144

XQ848

NOMESCO Finland

Dermatological photography

2.8

192.7

1025

3777

E000002, ,

ATC

1.8

191.7

3395

20057

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

12.0

191.5

193

162

L01AA01

ATC

cyclophosphamide; systemic

10.8

191.4

206

191

M19.2

ICD-10 Finland

Other secondary arthrosis

4.0

191.4

559

1426

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

191.1

11831

92763

N03AX16

ATC

[U] pregabalin

1.5

190.5

6718

47148

RK210, ,

NOMESCO Finland

13.1

189.7

181

139

M01AH02

ATC

rofecoxib; oral

1.7

189.0

3517

21070

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.6

188.8

1183

4731

NDG74

NOMESCO Finland

Fusion of first IP joint

11.3

186.6

195

173

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

186.0

2807

15797

M01AE02

ATC

naproxen; oral, rectal

1.4

185.6

17437

146748

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

185.1

5785

39499

ZXX09

NOMESCO Finland

Extent of procedure, more than 8 units

19.6

185.0

143

C03CA01

ATC

furosemide; systemic

1.5

182.9

7220

51825

NDF68

NOMESCO Finland

Operation for osteochondritis of several joints of hand, open

45.1

182.9

108

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

20.1

182.8

140

J01CA04

ATC

amoxicillin; systemic

1.5

181.1

25975

235395

RS221, ,

NOMESCO Finland

3.8

180.2

565

1515

A07EC03

ATC

olsalazine; oral

14.1

179.4

164

117

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

49.1

177.7

103

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.4

177.5

1323

5728

A02BC05

ATC

esomeprazole; systemic

1.4

176.0

12029

95567

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

175.7

3483

21208

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

19.0

175.7

138

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

174.5

6764

48299

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

174.3

6936

49791

K71

ICPC

Rheumatic fever/heart disease

44.9

174.2

103

3AC01, ,

NOMESCO Finland

4.7

174.1

407

875

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

174.0

2087

10880

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

3.6

173.3

591

1677

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

172.5

866

3094

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.7

172.1

561

1545

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

7.5

171.6

247

333

M05.0

ICD-10 Finland

Felty syndrome

25.1

171.3

120

7143D

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]

25.4

170.6

119

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

32.8

168.4

108

M08.1

ICD-10 Finland

Juvenile ankylosing spondylitis

39.3

167.1

102

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

10.1

166.1

187

185

SPAT1153

SPAT

Removal of sutures

1.4

165.8

8706

65832

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.8

165.6

846

3050

4AC07, ,

NOMESCO Finland

74.3

165.0

SPAT1202

SPAT

Intra-articular injection

2.7

164.0

942

3608

108

Kela drug reimbursment

Myasthenia gravis

10.3

163.8

183

179

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

3.7

163.5

529

1449

L04AX02

ATC

thalidomide; oral

60.8

163.4

RT171, ,

NOMESCO Finland

16.3

163.3

138

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

163.3

2377

13204

S97

ICPC

Chronic ulcer skin

2.0

162.7

1799

9107

A05AA02

ATC

ursodeoxycholic acid; oral

3.2

160.7

641

2008

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.2

160.3

332

644

L95

ICPC

Osteoporosis

2.3

159.8

1213

5290

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

159.8

2154

11671

ZX108

NOMESCO Finland

Inhalation

5.2

159.6

328

632

M05BA06

ATC

ibandronic acid; systemic

3.3

158.3

614

1891

WX320

NOMESCO Finland

Spinalanesthesy

1.5

158.2

6932

50579

NF1DA

NOMESCO Finland

X-ray of hips

3.0

157.7

705

2362

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

156.8

4393

29136

G70.0

ICD-10 Finland

Myasthenia gravis

8.0

156.2

212

267

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

3.2

155.9

616

1919

D05AA

ATC

Tars

6.2

155.5

265

428

9527

FHL

Alloarthroplasty, implant or endoprosthesis

37.0

154.8

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.7

154.7

247

373

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

28.2

154.6

104

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

154.3

2963

17848

L40.4

ICD-10 Finland

Guttate psoriasis

6.5

154.1

251

387

ZXA00

NOMESCO Finland

Right side

1.5

152.1

6948

51043

ZZH31

NOMESCO Finland

Bone allograft, small pieces

5.0

151.9

327

656

NHG22

NOMESCO Finland

Fusion of subtalar joint

5.3

150.7

307

587

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

20.2

150.7

115

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

42.9

150.6

B07.9

ICD-10 Finland

Verruca simplex

2.2

150.4

1266

5766

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

8.4

150.4

196

235

L03AB07

ATC

interferon beta-1a; parenteral

5.6

150.0

284

508

B02.9

ICD-10 Finland

Zoster without complication

1.9

149.9

2011

10871

WVA20

NOMESCO Finland

Medicine administration

2.5

148.9

948

3817

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

148.7

2814

16875

WX204

NOMESCO Finland

Axillary plexus blockaced

2.4

148.2

1063

4521

RJ421, ,

NOMESCO Finland

8.0

148.2

201

253

D02AX

ATC

Other emollients and protectives

2.4

147.5

1024

4291

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

6.5

147.4

240

370

JFH11

NOMESCO Finland

Laparoscopic colectomy

26.6

147.3

101

A46

ICD-10 Finland

Erysipelas

1.6

145.0

3996

26360

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

9.2

144.6

175

191

M02.8

ICD-10 Finland

Other reactive arthropathies

6.3

143.8

243

389

A02BA02

ATC

ranitidine; systemic

1.5

143.6

4935

34191

M31.1

ICD-10 Finland

Thrombotic microangiopathy

20.8

143.2

108

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.1

142.9

624

2062

L03AX13

ATC

glatiramer acetate; parenteral

6.4

142.7

238

376

L01FC01

ATC

daratumumab; parenteral

41.0

142.3

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.4

142.1

511

1501

4AA24, ,

NOMESCO Finland

60.8

141.8

S01BA01

ATC

dexamethasone; ophthalmic

2.4

141.8

1048

4516

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

141.7

1776

9381

M01AB55

ATC

diclofenac, combinations; oral

1.9

141.3

1775

9383

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

141.2

1387

6714

ND2CG

NOMESCO Finland

Extensive MRI of hand

8.0

141.1

190

237

5BA08, ,

NOMESCO Finland

6.5

141.0

229

352

NDC40

NOMESCO Finland

Secondary prosthetic replacement in of joint of finger or metacarpal

33.4

141.0

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

140.1

1078

4726

S01BA04

ATC

prednisolone; ophthalmic

3.0

139.7

647

2211

ZY010

NOMESCO Finland

Hospital outpatient

2.0

139.6

1642

8486

RJ411, ,

NOMESCO Finland

6.0

139.1

245

409

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

138.9

2092

11725

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

138.3

6274

45905

N03AX12

ATC

[U] gabapentin; oral

1.5

137.7

4521

30991

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

137.1

10419

83285

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

136.5

3881

25762

M79.6

ICD-10 Finland

Pain in limb

1.3

134.9

13335

110877

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

6.0

134.3

236

393

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

134.2

16033

137016

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.9

133.9

1953

10834

EG1CG

NOMESCO Finland

Extensive MRI examination of mandibular joint with high intensity magnet

7.9

133.7

182

230

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

133.4

1692

8971

Z2446

NOMESCO Finland

Social worker

1.9

133.1

1885

10358

TAB00

NOMESCO Finland

Lumbar puncture

2.1

133.1

1381

6821

NHG82

NOMESCO Finland

Fusion of other tarsal joint

4.0

133.0

380

954

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

12.5

132.9

130

104

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.8

132.8

667

2382

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

132.5

1376

6798

L88

ICD-10 Finland

Pyoderma gangrenosum

10.0

132.5

151

152

H46

ICD-10 Finland

Optic neuritis

4.3

132.4

349

825

J01MA14

ATC

moxifloxacin; systemic

1.7

132.4

2484

14838

R1250

NOMESCO Finland

Evaluation of functional capability

2.6

131.7

808

3195

M33.1

ICD-10 Finland

Other dermatomyositis

19.8

131.2

101

ND2AE

NOMESCO Finland

Hand and fingers ultrasound examination

10.8

130.8

141

131

N02AA05

ATC

oxycodone; systemic

1.5

130.7

4610

32051

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

130.1

3625

23931

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

13.3

130.1

123

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

8.0

129.7

175

219

L28

ICPC

Limited function/disability (L)

1.5

129.2

4945

34949

L12.0

ICD-10 Finland

Bullous pemphigoid

6.0

129.2

230

388

M16.7

ICD-10 Finland

Other secondary coxarthrosis

4.5

128.7

320

723

9272

FHL

Metatarsophalangeal joint resection

9.3

128.5

154

166

137

Kela drug reimbursment

Uraemia requiring dialysis

4.4

128.2

328

758

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

127.7

3314

21510

Z94.4

ICD-10 Finland

Liver transplant status

7.0

127.2

194

279

5550A

ICD-9 Finland

Regional enteritis, Small intestine

24.4

127.1

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

15.6

126.2

109

1XX32, ,

NOMESCO Finland

38.5

125.4

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

124.7

646

2346

M06.1

ICD-10 Finland

Adult-onset Still disease

20.2

124.5

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

124.5

11194

91444

N86

ICPC

Multiple sclerosis

4.7

124.3

288

615

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

11.2

123.1

129

115

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

4.5

122.3

303

683

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

122.2

3729

25104

M01AX17

ATC

nimesulide; oral

1.4

122.0

6207

46232

SPAT1255

SPAT

Intravenous administration of medicine

1.8

121.8

1826

10207

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

3.4

121.4

442

1309

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

121.0

3766

25457

M43.4

ICD-10 Finland

Other recurrent atlantoaxial subluxation

17.0

120.9

100

M01AX01

ATC

nabumetone; oral

2.1

120.4

1170

5636

A07AA09

ATC

vancomycin; oral

3.3

120.3

471

1459

C08CA05

ATC

nifedipine; systemic

1.9

120.1

1497

7885

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.5

120.0

778

3158

M04AA01

ATC

allopurinol; systemic

1.6

119.8

3000

19291

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

3.7

119.3

385

1053

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

119.2

3056

19758

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.6

119.0

2834

18000

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

118.8

1178

5718

L17

ICPC

Foot/toe symptom/complaint

1.4

118.7

9009

71621

NDG76

NOMESCO Finland

Fusion of DIP joint

4.1

118.6

327

800

N07AA02

ATC

pyridostigmine; systemic

5.7

118.4

221

390

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

34.1

118.2

Z85.6

ICD-10 Finland

Personal history of leukaemia

30.8

117.7

7148X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies

13.4

117.3

110

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

117.1

5500

40345

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.5

117.0

781

3213

5551A

ICD-9 Finland

Regional enteritis, Large intestine

28.9

116.9

J01AA02

ATC

doxycycline; systemic

1.3

116.7

23203

211078

M31.7

ICD-10 Finland

Microscopic polyangiitis

16.7

116.5

J01FA06

ATC

roxithromycin; oral

1.3

116.1

11073

90975

R06.0

ICD-10 Finland

Dyspnoea

1.4

116.0

7424

57414

YNB10

NOMESCO Finland

Collection of stem cells for transplant

12.3

116.0

115

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.8

115.9

606

2211

7143B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SEROPOSITIVA]

34.8

115.6

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

115.6

3982

27486

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

5.3

115.6

234

445

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

115.4

7598

59024

M05BA01

ATC

etidronic acid; systemic

6.2

115.0

197

320

2AB04, ,

NOMESCO Finland

9.0

114.8

141

157

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

114.7

11727

97250

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

114.5

1791

10138

ZXA05

NOMESCO Finland

Left side

1.4

114.2

6251

47085

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

113.4

1085

5194

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

25.5

113.4

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.9

113.4

1515

8162

RJ410, ,

NOMESCO Finland

6.5

112.9

183

281

E000007, ,

ATC

1.9

112.4

1567

8557

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

8.7

112.3

142

164

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.0

111.9

497

1659

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

111.8

2675

16995

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

111.4

4300

30355

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

5.1

111.2

233

457

H30.2

ICD-10 Finland

Posterior cyclitis

7.4

111.1

161

219

A12AA04

ATC

calcium carbonate; oral

3.1

110.5

476

1561

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

110.3

1871

10843

SPAT1325

SPAT

Vaccination

1.3

110.0

8720

69609

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

109.5

15757

136528

JFB20

NOMESCO Finland

Ileocaecal resection

5.4

109.0

214

396

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

5.1

109.0

230

454

E000006, ,

ATC

1.8

108.9

1857

10778

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

108.5

22174

201160

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.5

108.5

696

2811

R03AC02

ATC

salbutamol; inhalant

1.3

108.3

16403

142992

K83.0

ICD-10 Finland

Cholangitis

3.1

108.1

453

1462

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

107.7

7071

54797

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.0

107.6

484

1627

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

107.5

20918

188358

M34.0

ICD-10 Finland

Progressive systemic sclerosis

14.9

107.2

ZXD05

NOMESCO Finland

Urgent procedure

1.3

106.8

8114

64299

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.2

106.4

887

4019

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

6.0

106.3

187

312

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.8

106.0

330

881

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

105.9

4224

29985

ZXX08

NOMESCO Finland

Extent of procedure, 8 units

15.7

105.7

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.5

105.7

361

1026

SPAT1229

SPAT

Assessment of need for aid

1.7

105.5

1866

10943

M79.7

ICD-10 Finland

Fibromyalgia

2.1

105.2

1099

5437

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

16.2

105.1

M08.2

ICD-10 Finland

Juvenile arthritis with systemic onset

23.5

104.3

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

8.6

104.1

132

153

D05AX05

ATC

tazarotene; topical

11.3

104.1

109

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

103.7

2038

12300

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

53.7

103.3

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

103.3

6791

52587

RJ511, ,

NOMESCO Finland

9.3

103.3

124

134

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

103.1

1606

9074

ZXA10

NOMESCO Finland

Bilateral

1.4

103.0

4746

34600

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

5.1

103.0

216

424

132

Kela drug reimbursment

Sarcoidosis

4.7

102.8

241

520

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

102.7

936

4396

R2110

NOMESCO Finland

Giving the first information

1.7

102.3

1924

11473

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

102.3

7084

55286

SPAT1263

SPAT

Sampling

1.3

101.7

11759

98671

TNB10

NOMESCO Finland

Joint puncture, shoulder joint

8.2

101.2

134

164

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.4

101.0

736

3150

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

100.9

2408

15273

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

100.8

2021

12261

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

10.0

100.5

114

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.1

100.5

423

1369

RS222, ,

NOMESCO Finland

3.3

100.4

380

1153

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

100.3

1127

5723

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

6.0

100.1

178

300

J01DA01

ATC

[U] cefalexin

1.3

100.1

17781

157451

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

99.4

8344

66961

R60.0

ICD-10 Finland

Localized oedema

1.5

99.4

3346

22937

M49.5*C90.0

ICD-10 Finland

Vertebral fracture due to multiple myeloma

51.8

99.1

B03XA02

ATC

darbepoetin alfa; parenteral

2.6

99.1

581

2247

R06AE07

ATC

cetirizine; oral

1.3

99.0

12986

110635

J01FA10

ATC

azithromycin; systemic

1.3

98.1

17342

153291

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

8.3

98.0

128

154

ZXX06

NOMESCO Finland

Extent of procedure, 6 units

9.2

98.0

118

128

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.9

97.8

291

753

Z01.2

ICD-10 Finland

Dental examination

1.3

97.6

14302

123485

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

3.4

97.3

362

1087

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.2

97.2

862

4004

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

19.8

97.2

A11CC03

ATC

alfacalcidol; systemic

2.4

96.9

665

2770

ND2BG

NOMESCO Finland

MRI of hand

6.3

96.9

162

257

M25.4

ICD-10 Finland

Effusion of joint

2.9

96.8

461

1600

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.1

96.7

951

4598

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

16.2

95.7

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

15.4

95.4

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.4

95.4

649

2693

398

Kela drug reimbursment

Ixazomib

473.7

95.3

RD210, ,

NOMESCO Finland

2.6

95.3

565

2197

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

95.1

1802

10763

K07.60

ICD-10 Finland

Snapping jaw

1.8

95.0

1561

8955

9311

FHL

Knee cleansing surgery (synovectomy, debridement)

9.8

94.9

109

111

TEG10

NOMESCO Finland

Injection of diagnostic or therapeutic substance into mandibular joint

9.9

94.6

108

109

NHB10

NOMESCO Finland

Primary partial prosthetic replacement of ankle joint

9.1

94.2

115

127

L11

ICPC

Wrist symptom/complaint

1.6

94.0

2733

18138

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

94.0

2072

12877

RJ512, ,

NOMESCO Finland

10.2

93.9

105

103

9289

FHL

Other measure in this category

13.6

93.5

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.5

93.4

575

2277

RS121, ,

NOMESCO Finland

4.4

93.3

236

541

Z71.8

ICD-10 Finland

Other specified counselling

1.3

93.3

10134

84079

JN4AD

NOMESCO Finland

Body CT examination

1.5

93.2

3001

20364

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.7

93.2

506

1883

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

5.7

93.1

172

301

NC1AE

NOMESCO Finland

Elbow ultrasound examination

9.3

93.0

111

119

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

92.7

6077

46918

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

92.6

3290

22781

A01

ICPC

Pain general/multiple sites

1.5

92.0

2797

18743

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

8.2

91.9

121

147

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

91.8

1579

9178

M66.0

ICD-10 Finland

Rupture of popliteal cyst

2.9

91.8

437

1517

L12

ICPC

Hand/finger symptom/complaint

1.4

91.7

5030

37726

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

7.5

91.5

130

173

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

91.4

1323

7304

N02BA01

ATC

acetylsalicylic acid; systemic, rectal

14.7

91.0

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

90.5

8191

66255

A07AA02

ATC

nystatin; oral

1.8

90.4

1499

8620

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

90.3

1241

6740

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

90.2

7463

59607

1505

Kela drug reimbursment

Ixazomib

448.5

90.2

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

12.8

90.2

R5120

NOMESCO Finland

Preparation of an aid

2.3

90.0

736

3308

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.6

89.6

296

823

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

89.6

7066

56045

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.3

89.6

695

3056

RF410, ,

NOMESCO Finland

3.1

89.4

373

1201

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.9

89.2

1111

5842

RT350, ,

NOMESCO Finland

10.4

89.0

NHG20

NOMESCO Finland

Fusion of talocrural joint

4.2

88.6

235

559

NDL66

NOMESCO Finland

Transposition of tendon of wrist or hand, other tendon

5.4

88.5

173

319

WW409

NOMESCO Finland

Other aferesis

7.1

88.3

133

189

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.3

88.1

682

2995

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

87.7

1262

6952

RT231, ,

NOMESCO Finland

20.6

87.2

9283

FHL

Subtalar joint ossification surgery (or triple)

12.3

87.0

M32

ICD-10 Finland

Systemic lupus erythematosus

10.7

86.8

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

5.8

86.7

158

273

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

9.1

86.6

105

115

NHF80

NOMESCO Finland

Operation for debridement of toe joint, open

12.1

86.2

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.3

86.1

326

990

J02AC01

ATC

fluconazole; systemic

1.3

86.0

11364

96379

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

3.2

85.8

339

1057

D06BB04

ATC

podophyllotoxin; topical

1.8

85.7

1407

8065

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

85.7

3761

50962

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

3.4

85.0

308

910

E85.3

ICD-10 Finland

Secondary systemic amyloidosis

21.7

85.0

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

9.9

84.9

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

7.9

84.7

115

145

N04.80

ICD-10 Finland

Congenital nephrotic syndrome of the Finnish type

45.5

84.5

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

84.2

1414

8158

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

6.6

84.2

134

202

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

84.1

3283

23136

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

16.1

83.7

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

5.0

83.6

180

362

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.0

83.4

961

4921

RF120, ,

NOMESCO Finland

3.1

83.2

351

1138

L01EX09

ATC

nintedanib; oral

7.3

82.5

120

164

RJ420, ,

NOMESCO Finland

5.4

82.4

163

304

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

7.5

82.2

117

156

K60.3

ICD-10 Finland

Anal fistula

2.5

82.1

518

2076

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.9

82.0

242

623

EG1DG

NOMESCO Finland

Very extensive MRI examination of mandibular joint with high intensity magnet

11.2

81.8

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.5

81.5

199

444

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

5.6

81.3

154

276

M05.2

ICD-10 Finland

Rheumatoid vasculitis

21.0

81.2

L01XE31

ATC

[U] nintedanib

10.5

81.1

K02.1

ICD-10 Finland

Caries of dentine

1.3

80.7

17943

161144

M35.7

ICD-10 Finland

Hypermobility syndrome

2.7

80.5

452

1711

N05.8

ICD-10 Finland

Unspecified nephritic syndrome, other

19.1

80.4

QDH05

NOMESCO Finland

Correction of deformity of toe nail

5.7

80.1

148

259

I77.6

ICD-10 Finland

Arteritis, unspecified

7.4

80.0

115

155

S01FA04

ATC

cyclopentolate; ophthalmic

3.2

79.8

318

997

R3130

NOMESCO Finland

Training in activities of daily lining

23.8

79.6

1370

FHL

Colonoscopy, whole colon

5.0

79.5

169

336

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

2.3

79.3

591

2554

Z22.30

ICD-10 Finland

Latent tuberculosis

15.3

79.2

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.5

79.2

508

2052

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

79.1

3035

21300

D09AB01

ATC

zinc bandage without supplements; topical

2.4

79.0

533

2203

RF420, ,

NOMESCO Finland

2.8

78.6

402

1451

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

78.5

858

4312

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.2

78.4

677

3111

9260

FHL

Alloarthroplasty, endoprosthesis or implant

22.8

78.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

78.0

10610

89991

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.7

78.0

1351

7863

H15.1

ICD-10 Finland

Episcleritis

2.6

77.7

475

1875

ACC51

NOMESCO Finland

Release of median nerve

1.6

77.7

2043

13234

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.6

77.6

258

721

Z93.2

ICD-10 Finland

Ileostomy status

5.2

77.5

158

303

A03

ICPC

Fever

1.4

77.3

5047

38807

R5110, ,

SPAT

1.6

77.3

2200

14508

9531

FHL

Arthrodesis of the hand joint

5.8

77.3

141

244

602

Kela drug reimbursment

Children's severe malnutrition

6.1

77.1

134

221

5AB14, ,

NOMESCO Finland

7.9

77.1

105

133

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

76.7

968

5111

JF1CM

NOMESCO Finland

Small bowel extensive MRI with with high intensity magnet

17.7

76.4

JF1DM

NOMESCO Finland

Very extensive MRI of small bowel (more than 1.5 T)

19.7

76.3

D11AH01

ATC

tacrolimus; topical

3.0

75.9

333

1105

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

75.8

2376

16000

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

75.7

1546

9408

R4190

NOMESCO Finland

Nutritional therapy

1.8

75.5

1171

6598

AA1AA

NOMESCO Finland

Head X-ray examination

3.6

75.5

247

683

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

75.5

690

3244

RJ412, ,

NOMESCO Finland

7.9

75.0

102

129

TK800

NOMESCO Finland

Hemodialysis

2.3

74.8

566

2462

NHM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot

3.9

74.7

219

561

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

1.9

74.7

954

5057

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.0

74.7

776

3829

R05

ICD-10 Finland

Cough

1.3

74.6

5976

47317

L26

ICD-10 Finland

Exfoliative dermatitis

7.2

74.5

110

153

JHA00

NOMESCO Finland

Anal or perianal incision

2.6

74.4

423

1612

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

5.6

74.4

141

253

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

74.4

1109

6175

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

74.1

1247

7195

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

15.6

74.1

L93.0

ICD-10 Finland

Discoid lupus erythematosus

4.3

74.1

191

445

5559X

ICD-9 Finland

Regional enteritis, Unspecified site

32.0

74.0

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.1

73.9

312

1012

C90.2

ICD-10 Finland

Extramedullary plasmacytoma

13.5

73.9

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

5.1

73.8

155

305

N02BF01

ATC

gabapentin; oral

1.5

73.6

2857

20081

S01XA18

ATC

ciclosporin; ophthalmic

3.3

73.6

273

819

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

73.4

1495

9089

SBA10

NOMESCO Finland

Measurement of salivary flow rate

3.1

73.3

317

1043

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

4.6

73.2

174

380

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

73.1

9578

80724

M31.6

ICD-10 Finland

Other giant cell arteritis

5.9

72.9

130

220

WW400

NOMESCO Finland

Plasmaferesis

7.4

72.9

105

142

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

72.7

1689

10616

395

Kela drug reimbursment

Dupilumab

5.9

72.5

129

218

L84

ICD-10 Finland

Corns and callosities

1.9

72.3

935

4976

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

3.9

72.0

215

558

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

5.4

71.9

141

261

D11AH04

ATC

alitretinoin; oral

9.5

71.9

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

2.4

71.8

504

2122

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.2

71.7

633

2936

M02AA07

ATC

piroxicam; topical

1.3

71.6

9123

76596

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

12.5

71.5

A28

ICPC

Limited function/disability NOS

1.4

71.3

3953

29582

Z94.1

ICD-10 Finland

Heart transplant status

6.5

70.9

116

180

3060, ,

Kela drug reimbursment

87.9

70.9

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

4.4

70.7

178

407

D07AA02

ATC

hydrocortisone; topical

1.4

70.5

3718

27592

H15.0

ICD-10 Finland

Scleritis

4.7

70.4

161

341

D11AH05

ATC

dupilumab; topical

5.6

70.2

132

235

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

30.7

70.0

1534, ,

Kela drug reimbursment

86.8

69.9

SFA10

NOMESCO Finland

One-surface restoration

1.2

69.9

16448

147545

L40.1

ICD-10 Finland

Generalized pustular psoriasis

12.9

69.7

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

69.7

6934

56441

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

7.0

69.4

105

150

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

69.4

4531

34782

R11

ICD-10 Finland

Nausea and vomiting

1.5

69.3

2309

15736

B05DA

ATC

Isotonic solutions

3.6

69.3

231

647

RJ190, ,

NOMESCO Finland

6.8

69.0

108

160

6BA02, ,

NOMESCO Finland

5.5

69.0

134

246

WZA00

NOMESCO Finland

Concise certificate

1.6

68.9

1775

11432

SPAT1301

SPAT

No procedures

1.3

68.8

8146

67728

M60.9

ICD-10 Finland

Myositis, unspecified

4.0

68.8

198

501

RT172, ,

NOMESCO Finland

9.3

68.7

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

68.6

22096

204677

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

68.1

4386

33590

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.7

68.0

1169

6786

N02BF02

ATC

pregabalin; oral

1.6

68.0

1860

12147

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.7

67.7

1365

8275

RT160, ,

NOMESCO Finland

8.5

67.5

103

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.1

67.5

646

3091

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.4

67.2

477

2018

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

67.1

5222

41099

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.4

66.8

485

2073

L03AB08

ATC

interferon beta-1b; parenteral

5.6

66.7

125

222

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

4.5

66.5

164

369

J04BA02

ATC

dapsone; oral

4.0

66.4

191

483

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

3.1

66.4

277

893

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.9

66.3

313

1082

Z50.1

ICD-10 Finland

Other physical therapy

1.7

66.1

1305

7867

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

2.0

65.9

757

3872

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.6

65.9

1833

12015

TEG00

NOMESCO Finland

Punction of mandibular joint

8.3

65.6

104

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

65.6

1380

8458

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

65.6

945

5206

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

6.4

65.5

108

169

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

65.0

5702

45597

H26.2

ICD-10 Finland

Complicated cataract

2.7

64.9

359

1350

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

4.7

64.8

150

321

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

64.6

707

3555

UJF02

NOMESCO Finland

Peroral enteroscopy

3.7

64.5

201

538

M15.3

ICD-10 Finland

Secondary multiple arthrosis

5.1

64.4

136

269

Z94.2

ICD-10 Finland

Lung transplant status

6.7

64.4

101

150

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.6

64.4

386

1510

RT274, ,

NOMESCO Finland

7.1

64.4

135

NH1AD

NOMESCO Finland

Ankle and foot CT

2.0

64.4

668

3295

M54.5

ICD-10 Finland

Low back pain

1.2

64.1

10471

90121

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

63.9

3656

27464

ZX100

NOMESCO Finland

Oral

2.6

63.9

365

1395

K76.9

ICD-10 Finland

Liver disease, unspecified

2.6

63.8

387

1523

NDG71

NOMESCO Finland

Arthrodes of first MP joint

5.1

63.7

132

257

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

2.0

63.7

685

3423

L16

ICPC

Ankle symptom/complaint

1.4

63.6

3297

24371

NCM20

NOMESCO Finland

Excision of synovial ganglion of elbow or forearm

5.0

63.6

137

276

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

6.9

63.5

140

A02BB01

ATC

misoprostol; oral

4.1

63.3

175

430

L04AA05

ATC

[U] tacrolimus

10.1

63.2

H57.1

ICD-10 Finland

Ocular pain

1.7

63.1

1106

6454

SFA20

NOMESCO Finland

Two-surface restoration

1.2

63.0

17480

158654

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

62.9

2941

21358

M06.2

ICD-10 Finland

Rheumatoid bursitis

21.4

62.9

WW500

NOMESCO Finland

Blood transfusion

1.8

62.8

981

5537

L30.3

ICD-10 Finland

Infective dermatitis

1.8

62.5

927

5152

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.1

62.2

567

2663

D05AC01

ATC

dithranol; topical

11.0

62.2

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

62.1

2265

15705

M11.2

ICD-10 Finland

Other chondrocalcinosis

4.9

62.0

136

278

L04AA31

ATC

[U] teriflunomide

5.2

61.9

127

245

M01AB01

ATC

indometacin; systemic, rectal

1.6

61.8

1539

9830

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

20.4

61.7

RF212, ,

NOMESCO Finland

5.0

61.7

133

268

V03AG01

ATC

sodium cellulose phosphate; systemic

8.9

61.7

4AA09, ,

NOMESCO Finland

22.5

61.4

M02.3

ICD-10 Finland

Reiter disease

7.9

61.4

107

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

61.1

5543

44471

M94.1

ICD-10 Finland

Relapsing polychondritis

14.5

61.1

N06AX21

ATC

duloxetine; oral

1.4

61.1

3220

23856

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

61.1

1680

10979

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.9

60.9

725

3754

C08CA01

ATC

amlodipine; oral

1.2

60.8

9489

81151

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

60.8

2936

21435

0108, ,

NOMESCO Finland

23.2

60.7

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

2.4

60.4

434

1847

TFJ02

NOMESCO Finland

Muscle biopsy of heart

6.2

60.4

103

167

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

60.4

1588

10272

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.8

59.9

886

4919

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

59.9

3541

26721

R05

ICPC

Cough

1.3

59.7

6970

57674

C07AB07

ATC

bisoprolol; oral

1.2

59.7

12130

106545

RJ210, ,

NOMESCO Finland

5.8

59.7

109

189

ZX114

NOMESCO Finland

Intramuscular

2.4

59.6

413

1730

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

59.5

718

3735

M35.2

ICD-10 Finland

Behçet disease

14.2

59.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

59.4

5220

41690

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

11.3

59.3

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

4.4

59.2

146

329

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

10.0

59.1

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

16.9

59.0

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.8

58.9

984

5663

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

7.4

58.2

114

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.6

58.2

348

1361

L03AA02

ATC

filgrastim; parenteral

1.9

58.1

738

3904

M48.0

ICD-10 Finland

Spinal stenosis

1.4

58.0

2822

20621

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

58.0

2428

17277

212

Kela drug reimbursment

Gout

2.4

57.9

400

1673

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.3

57.9

218

661

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

57.7

2552

18336

N06AA09

ATC

amitriptyline; systemic

1.5

57.6

2251

15809

7143X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS NUD]

21.5

57.6

L01XG03

ATC

ixazomib; oral

568.5

57.6

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.1

57.6

585

2863

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

57.5

1165

7068

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

6.4

57.5

146

XQ802

NOMESCO Finland

Epicutan test

1.7

57.4

1070

6351

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

57.2

791

4301

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

57.1

7071

58868

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.8

56.7

800

4377

ZXC50

NOMESCO Finland

Cryotherapy

1.9

56.7

682

3543

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

56.7

16165

146410

M16.6

ICD-10 Finland

Other secondary coxarthrosis, bilateral

5.4

56.7

112

209

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

2.3

56.7

425

1843

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4.0

56.7

161

404

M01AB08

ATC

etodolac; oral

1.5

56.5

1742

11667

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

5.3

56.4

112

210

I73.0

ICD-10 Finland

Raynaud syndrome

2.2

56.3

493

2279

69600

ICD-8 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

12.2

56.3

M03BX02

ATC

tizanidine; oral

1.2

56.2

18212

166868

M31.0

ICD-10 Finland

Hypersensitivity angiitis

15.3

56.1

K51.4

ICD-10 Finland

Inflammatory polyps

12.9

56.1

SFA30

NOMESCO Finland

Three-surface restoration

1.2

56.0

11917

104938

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.3

56.0

412

1772

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.5

56.0

343

1357

B02

ICD-10 Finland

Zoster [herpes zoster]

1.7

56.0

1116

6743

J01FA09

ATC

clarithromycin; systemic

1.2

55.9

8507

72412

A98

ICPC

Health maint/preventive medicine

1.6

55.9

31209

304679

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.5

55.8

359

1453

M31.4

ICD-10 Finland

Aortic arch syndrome [Takayasu]

21.0

55.7

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

55.7

1481

9600

H20

ICD-10 Finland

Iridocyclitis

3.6

55.7

181

499

L04AG12

ATC

ofatumumab; parenteral

8.6

55.7

K61.0

ICD-10 Finland

Anal abscess

2.2

55.7

458

2065

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

3.5

55.7

194

560

B01AB10

ATC

tinzaparin; parenteral

1.4

55.5

2794

20523

JJC00

NOMESCO Finland

Allogenic transplantation of liver

5.3

55.5

110

206

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

3.0

55.4

253

860

B74

ICPC

Malignant neoplasm blood other

6.2

55.2

149

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

55.2

3055

22794

WX892

NOMESCO Finland

Monitored bed care

1.5

55.1

1794

12152

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

8.7

55.0

M05.1

ICD-10 Finland

Rheumatoid lung disease

24.4

54.8

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

54.8

1862

12722

L15

ICPC

Knee symptom/complaint

1.3

54.6

6897

57492

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

54.5

855

4831

L52

ICD-10 Finland

Erythema nodosum

3.1

54.5

228

737

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

54.4

7256

60854

L28.1

ICD-10 Finland

Prurigo nodularis

3.2

54.4

221

702

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

54.3

1278

8052

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.9

54.1

650

3376

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

3.7

54.0

174

477

4AB0M, ,

NOMESCO Finland

186.7

53.9

A10AC01

ATC

insulin (human); parenteral

1.5

53.9

1656

11081

SAA04

NOMESCO Finland

Special examination of mouth

1.6

53.9

1367

8766

M02.1

ICD-10 Finland

Postdysenteric arthropathy

5.0

53.8

116

234

L57.0

ICD-10 Finland

Actinic keratosis

1.4

53.6

2314

16547

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

53.6

1692

11387

GDG10

NOMESCO Finland

Bilateral transplantation of lung

7.3

53.5

107

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

5.7

53.5

174

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

53.5

1659

11124

135

Kela drug reimbursment

Pemphigus

21.0

53.1

D05AX

ATC

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1468

4986

3.03

322.40

1.7

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

13158

97934

1.57

320.01

3.6

3.5

2.35

2.36

mmol/l

23.35

12284

89389

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

690

1391

5.04

318.93

1.1

1503.62

1544.95

miu/ml

0.39

690

1391

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2091

8631

2.52

315.17

2.8

2.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5251

31002

1.82

308.31

2.2

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6226

30859

2.26

307.65

4.9

4.5

241.37

242.11

u/l

0.14

5982

29369

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

16827

114394

1.97

307.65

6.1

3.5

0.12

0.52

estimate

2.55

5549

24167

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1142

2113

5.56

307.65

1.3

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1586

4001

4.11

307.65

2.2

1.3

10.73

16.56

u/ml

1.27

(3026782) Osmolality of Urine

8206

52321

1.76

307.65

3.9

2.8

525.97

531.55

mosm/kgh2o

1.48

7481

45696

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

27246

238652

1.87

307.65

37.4

17.3

14.01

13.51

307.65

27170

235480

(4062490) Immunoglobulin typing, IgG

1050

2811

3.82

307.65

1.7

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

687

859

8.14

307.65

1.6

3234.42

3660.72

titre

0.51

129

122

(3045424) Erythrocytes [Presence] in Urine

3770

12773

3.20

307.65

2.5

2.0

0.01

0.17

estimate

1.06

1415

3991

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

13055

48308

3.84

307.65

1.5

1.3

41.64

3.77

u/ml

177.39

5630

18738

(3025159) Blasts/Leukocytes in Blood

8427

21753

4.88

307.65

8.4

3.8

0.17

0.36

1.76

2295

5415

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

886

2133

4.24

307.65

1.4

1.2

227.35

181.15

titre

0.85

249

253

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

2851

1611

19.28

307.65

1.1

1.55

2.24

iu/ml

0.90

(3001604) Monocytes [#/volume] in Blood

30097

141833

16.46

307.65

18.6

4.8

0.58

0.57

e9/l

3.34

28602

120815

(3039162) Centromere protein B Ab [Units/volume] in Serum

1491

3285

4.70

307.65

1.4

1.2

48.50

58.36

u/ml

0.64

111

175

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

22068

129360

3.20

307.65

3.7

2.4

77.32

771.92

nmol/l

0.50

21267

117940

(3001122) Ferritin [Mass/volume] in Serum or Plasma

18533

141770

1.71

307.65

4.1

3.1

134.23

116.12

ug/l

13.48

17706

133231

(3000850) Epithelial cells [#/volume] in Urine

10831

61096

2.16

307.65

3.7

2.6

4.73

6.00

e6/l

15.69

10161

55341

(21494815) CD4 cells/Lymphocytes in Specimen

953

2251

4.33

307.65

2.2

2.3

43.32

37.77

19.35

939

2216

(3018095) Leukocytes [#/volume] in Urine

16629

104369

2.21

307.65

5.8

3.8

69.41

90.05

e6/l

2.74

12054

72095

(3006571) Granulocytes/Leukocytes in Synovial fluid

2078

2218

9.93

307.65

1.9

1.3

50.72

60.13

13.61

1422

1302

(3018333) Ribosomal P Ab [Presence] in Serum

1094

1971

5.70

307.65

1.3

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

12024

85726

1.64

307.65

2.8

2.2

152.92

206.77

u/l

14.61

11556

81093

(3047189) Immunofixation for 24 hour Urine

556

894

6.30

307.65

2.7

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

3956

5360

8.25

307.65

1.8

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

12540

83320

1.82

307.65

4.1

2.7

0.12

0.06

0.88

147

1720

(3007566) Smooth muscle Ab [Titer] in Serum

2407

8092

3.13

307.65

1.5

1.2

170.56

107.32

titre

1.78

266

746

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

915

1814

5.15

307.65

2.7

1.5

3.76

3.66

mg/l

0.24

882

1743

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

3037

7617

4.29

307.65

1.4

1.3

6.47

4.88

u/ml

0.46

412

617

(3035350) Ketones [Presence] in Urine by Test strip

23887

151453

3.18

307.65

6.1

3.6

5.98

3.74

estimate

1.15

6365

30262

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1121

2036

5.66

307.65

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1114

2033

5.63

307.65

1.3

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2489

7021

3.75

307.65

1.2

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

7963

5233

19.81

307.65

1.6

1.5

3.10

7.83

iu/ml

0.57

1407

956

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3291

9370

3.79

307.65

1.6

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

1068

2859

3.82

307.65

1.7

1.3

2.84

2.94

g/l

0.93

772

2078

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2197

7332

3.14

307.65

2.8

2.0

11.20

11.32

mg/l

0.27

2069

6886

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1739

3866

4.69

307.65

1.1

0.46

8.23

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2893

6407

4.85

307.65

1.4

1.2

24.18

12.26

u/ml

0.94

(3024561) Albumin [Mass/volume] in Serum or Plasma

19818

124653

2.51

307.65

8.7

4.8

35.84

36.07

g/l

8.16

19130

116884

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

2280

6229

3.86

307.65

1.4

1.2

53.52

40.18

u/ml

2.80

317

485

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2291

7165

3.36

307.65

9.0

2.0

9.26

2.70

ratio

3.13

1381

4023

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

31514

281032

5.18

307.65

32.2

14.1

17.23

23.89

mg/l

307.65

29452

227587

(3020630) Protein [Mass/volume] in Serum or Plasma

5255

21098

2.77

307.65

5.7

2.1

66.26

66.52

g/l

1.59

4977

19394

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

3320

8447

4.26

307.65

2.7

1.5

1.17

1.20

g/l

4.47

3209

8087

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

414

53.00

307.65

1.8

1.6

1.72

1.82

mg/l

0.27

353

(3010144) Erythrocytes [#/volume] in Synovial fluid

1355

1845

7.61

307.65

1.8

1.2

43063.91

163628.39

e6/l

7.42

926

1187

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2705

6276

4.60

307.65

1.4

1.2

3.85

5.75

u/ml

0.62

234

368

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

30053

209419

6.87

307.65

12.5

3.6

13.39

11.20

mm/h

129.99

29554

196257

(40761536) Microorganisms panel - Urine sediment

4144

22055

2.00

307.65

5.4

3.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

11234

77953

1.67

307.65

1.9

1.7

20.39

20.22

nmol/l

0.41

9879

66666

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

949

2254

4.30

307.65

1.3

1.2

80.58

65.16

u/ml

0.57

(3041096) Erythrocytes [Presence] in Urine by Automated

12314

82628

1.79

307.65

4.9

3.1

0.11

0.26

estimate

1.30

5529

23630

(21494890) Protein electrophoresis panel - 24 hour Urine

1002

2231

4.60

307.65

3.8

1.6

—

(3022096) Basophils/Leukocytes in Blood

27415

130341

8.10

307.65

19.2

5.0

0.76

0.68

130.55

27060

121739

(3017354) Segmented neutrophils/Leukocytes in Blood

1002

2542

4.03

307.65

3.4

57.38

57.17

0.11

887

2177

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

30210

269299

2.75

307.65

26.4

13.9

86.13

83.59

ml/min/173m2

85.66

29029

246955

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

13149

52989

3.49

307.65

1.5

1.3

70.33

24.18

iu/ml

51.02

5475

14916

(3021589) Normoblasts [#/volume] in Blood

22126

126087

3.37

307.65

23.7

9.9

0.00

e9/l

4.82

19997

101418

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1659

4661

3.69

307.65

1.5

1.2

155.79

112.40

titre

0.49

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1647

4615

3.70

307.65

1.5

1.2

416.30

189.48

titre

4.37

211

270

(3004809) Band form neutrophils/Leukocytes in Blood

1521

3947

3.99

307.65

3.4

1.05

1.68

10.07

1404

3529

(3030981) Hyaline casts [#/volume] in Urine by Automated count

4154

22052

2.01

307.65

2.9

2.4

0.25

0.42

e6/l

9.81

3923

21065

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2839

10127

2.97

307.65

5.3

1.7

7.44

7.33

g/l

3.00

2686

9254

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

414

120

34.88

307.65

1.1

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2521

8707

3.05

307.65

5.5

1.8

1.16

0.64

g/l

7.36

2193

7545

(3045414) Leukocytes [Presence] in Urine

5797

26058

2.49

307.65

2.4

2.0

0.01

0.03

estimate

3.16

1543

5159

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2672

5309

5.39

307.65

6.4

6.0

465.29

1303.13

iu/ml

1.65

385

770

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5273

18976

3.12

307.65

2.1

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

790

1733

4.64

307.65

2.5

2.6

430.86

543.91

e6/l

7.44

623

1386

(3004616) Nuclear Ab [Presence] in Serum

1275

3311

3.96

307.65

1.4

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

520

698

7.54

307.65

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2510

9807

2.69

307.65

1.5

1.3

—

(3019198) Lymphocytes [#/volume] in Blood

30136

145512

16.01

307.65

18.8

4.8

1.81

1.95

e9/l

73.06

28880

127175

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

19942

149545

1.86

307.65

8.3

6.5

10.36

11.31

umol/l

31.65

19288

142270

(3014148) Varicella zoster virus Ab [Titer] in Serum

1704

3634

4.89

307.65

1.1

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

3037

7593

4.30

307.65

1.4

1.3

13.30

6.07

u/ml

5.19

618

956

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1143

2117

5.55

307.65

1.3

1.1

—

(3006504) Eosinophils/Leukocytes in Blood

27535

130262

8.34

307.65

18.9

4.9

2.75

2.86

14.80

27181

121801

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

822

1785

4.69

307.65

2.6

2.7

196.06

237.68

e6/l

3.82

691

1496

(46235355) HIV 1 and 2 tests - Meaningful Use set

11004

56831

2.41

307.65

1.8

2.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

4261

10295

4.61

307.65

1.4

1.2

1.17

0.74

u/ml

1.19

343

803

(3023420) DNA double strand Ab [Units/volume] in Serum

5896

10098

6.90

307.65

2.4

1.6

10.03

6.51

iu/ml

3.49

1598

2222

(3015736) pH of Urine

19810

120834

2.64

307.65

5.1

3.2

6.26

6.21

9.81

10477

67909

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2383

8753

2.85

307.65

5.3

1.7

10.19

10.08

g/l

0.43

2204

7800

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1593

5448

3.02

307.65

1.7

1.5

141.87

147.69

au/ml

0.87

398

1607

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1732

5876

3.05

307.65

1.7

1.4

28.75

20.58

u/ml

1.09

116

(3037522) Nuclear Ab [Titer] in Serum

13585

38052

5.41

307.65

1.6

1.3

608.19

495.84

titre

8.31

3744

7221

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1744

4366

4.16

307.65

4.6

2.8

2871.25

8211.97

u/ml

0.76

126

227

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

689

411

17.08

307.65

1.8

1.5

9.00

9.65

ug/l

1.49

689

411

(3029937) Albumin [Presence] in Urine by Test strip

14065

81165

2.29

307.65

6.5

3.8

0.00

0.01

estimate

0.81

6099

27504

(3024980) IgG subclass 4 [Mass/volume] in Serum

1703

4613

3.84

307.65

2.0

1.5

0.75

g/l

0.02

1327

3614

(3034891) Synovial lining cells/cells in Synovial fluid

887

858

10.59

307.65

1.7

1.3

4.72

3.46

1.01

223

162

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1389

4404

3.25

307.65

2.1

1.6

—

(3023368) Bacteria identified in Blood by Culture

11801

73485

1.95

307.65

5.3

4.3

—

(3034770) Mitochondria Ab [Titer] in Serum

2361

7959

3.12

307.65

1.4

1.2

955.00

907.81

titre

0.09

228

(3023520) Reticulocytes [#/volume] in Blood

5119

22699

2.49

307.65

2.9

2.7

69.55

70.19

e9/l

0.59

3777

16478

(3011412) CD3 cells [#/volume] in Blood

1121

2407

4.78

307.65

2.4

2.5

1099.62

1228.09

e6/l

3.78

976

2098

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1953

5616

3.63

307.65

1.5

1.3

279.72

255.02

u/ml

2.55

1186

3600

(3037467) Urinalysis macro (dipstick) panel - Urine

27192

192361

3.54

307.65

8.1

4.2

2.47

4.27

0.47

276

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2836

10111

2.97

307.65

5.3

1.7

4.23

g/l

0.09

2685

9250

(3042936) Bacteria identified in Isolate by Culture

7219

39288

2.07

307.65

2.4

2.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

30299

160188

14.44

307.65

22.2

8.3

3.92

4.09

e9/l

48.07

28890

137499

(40768443) Skin Pathology biopsy report

2752

12577

2.29

307.65

1.4

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

5689

33714

1.83

307.65

2.0

1.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2794

11726

2.51

307.65

1.9

1.8

1.55

1.52

g/l

0.62

2436

10119

(36304419) Bacteria [Presence] in Urine

12001

74523

1.97

307.65

4.3

3.1

263.64

114.68

estimate

0.25

284

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2707

9582

2.99

307.65

5.4

1.7

2.99

2.85

g/l

8.63

2554

8711

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3851

10865

3.88

307.65

2.7

1.3

18.00

7.82

iu/ml

5.57

293

150

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2522

8126

3.28

307.65

9.5

2.1

53.68

39.38

mg/l

1.73

2150

6904

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

332

47.17

307.65

1.7

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1858

6719

2.87

307.65

5.2

1.8

0.00

g/l

-0.00

1763

6295

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

351

64.42

307.65

2.6

2.3

3.33

3.06

mg/l

0.42

340

(3048689) Calprotectin [Mass/mass] in Stool

9627

38367

3.14

307.65

6.7

1.8

193.48

116.58

ug/g

73.58

8698

29893

(3034860) Kappa light chains.free [Mass/volume] in Serum

2519

8145

3.26

307.65

9.5

2.1

54.08

61.40

mg/l

0.36

2149

6922

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1515

233

68.06

307.65

2.2

2.0

9.15

8.83

mg/l

0.42

1252

191

(3037756) Immunofixation for Serum or Plasma

1808

4647

4.06

307.65

3.0

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

887

2127

4.25

307.65

1.4

1.2

257.41

118.00

titre

1.39

(3022948) Iron [Moles/volume] in Serum or Plasma

9117

47550

2.27

307.65

3.1

2.6

12.88

13.89

umol/l

1.69

8718

44410

(3002179) Metamyelocytes/Leukocytes in Blood

8564

21190

5.12

307.65

7.1

3.5

0.43

0.80

35.69

2587

6264

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

720

1252

5.85

307.65

1.1

—

(3032080) INR in Blood by Coagulation assay

16359

125574

1.61

307.65

13.5

13.3

1.19

1.22

inr

14.33

13814

104366

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2835

10096

2.98

307.65

5.3

1.7

3.72

3.70

g/l

0.22

2683

9232

(3010503) CD19 cells [#/volume] in Blood

698

1401

5.06

307.65

2.2

2.8

146.33

355.27

e6/l

1.67

678

1365

(3018418) pH of Serum or Plasma

13712

82955

2.13

307.65

6.4

4.1

7.40

0.81

10239

58588

(3017143) Hepatitis C virus Ab [Presence] in Serum

9898

33438

3.81

307.65

1.5

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3727

18970

2.09

307.65

1.3

50.61

50.92

au/ml

0.03

185

1219

(3002030) Lymphocytes/Leukocytes in Blood

27680

134464

8.19

307.65

18.8

5.0

27.81

28.44

21.64

27371

127264

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

20191

139937

2.17

307.65

11.1

7.0

1.22

1.21

mmol/l

3.92

17893

121173

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3141

11738

2.85

307.65

2.8

1.9

37.73

40.21

u/l

9.33

2900

10493

(3026493) Urate [Moles/volume] in Serum or Plasma

13178

72750

2.36

307.65

3.5

2.6

321.82

338.39

umol/l

71.78

12164

64530

(3011397) Hemoglobin [Presence] in Urine by Test strip

11867

68389

2.16

307.65

6.0

3.5

0.57

0.29

1.01

627

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1699

6058

2.90

307.65

1.7

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5613

32850

1.85

307.65

2.2

1.8

—

(3002582) Erythrocytes [#/volume] in Urine

14010

90585

1.96

307.65

4.7

3.3

44.41

77.47

e6/l

4.31

11629

67810

(3027945) Reticulocytes/Erythrocytes in Blood

6321

29789

2.39

307.65

3.5

2.6

1.81

1.77

1.97

5872

26605

(3013115) Eosinophils [#/volume] in Blood

30192

147040

16.13

307.65

19.1

5.0

0.18

0.19

e9/l

45.61

28905

127430

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1641

220

78.40

307.65

3.5

4.0

8.59

8.74

mg/l

0.10

1335

170

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1920

6640

3.01

307.65

2.0

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1970

6879

2.98

307.65

2.1

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

30434

215055

7.67

307.65

17.8

7.4

73.82

79.02

u/l

128.97

30164

204077

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3191

9325

3.68

307.65

1.3

1.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1218

2630

4.77

307.65

1.3

1.2

53.04

42.02

u/ml

0.63

123

(3021440) Promyelocytes/Leukocytes in Blood

8435

21395

4.97

307.65

7.9

3.7

0.07

0.14

10.13

2345

5611

(3038026) Centromere Ab [Units/volume] in Serum

855

1898

4.59

307.65

1.3

1.2

56.10

50.72

u/ml

0.18

119

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12990

71875

2.34

307.65

3.2

2.3

2.88

2.74

mg/l

11.42

11841

62091

(3008898) HLA-B27 [Presence]

3718

9532

4.27

307.65

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3979

20561

2.06

307.65

2.4

22.19

21.15

au/ml

0.32

365

2418

(3021601) Nitrite [Presence] in Urine by Test strip

23794

149653

3.20

307.65

6.0

3.6

0.00

estimate

2.38

6278

29655

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

3284

8177

4.35

307.65

2.7

1.5

0.22

0.24

g/l

23.37

3163

7799

(40758558) Short blood count panel - Blood

14719

85333

2.32

307.65

12.4

5.8

—

(3018010) Neutrophils/Leukocytes in Blood

27549

131783

8.21

307.65

18.4

4.9

57.95

56.70

70.88

27286

125706

(3019069) Monocytes/Leukocytes in Blood

27609

130616

8.45

307.65

19.0

5.0

9.07

8.70

102.75

27252

122246

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5554

27607

2.22

307.65

2.4

2.3

340.19

381.88

nmol/l

45.64

5270

25670

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1448

196

77.17

307.65

2.7

3.2

149.84

138.85

au/ml

0.16

219

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1751

5911

3.07

307.65

1.7

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

703

941

7.60

307.65

28.7

31.9

118.24

118.67

ug/l

0.04

605

760

(3024263) Appearance of Synovial fluid

611

1038

5.97

307.65

2.7

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

1067

2859

3.82

307.65

1.7

1.3

0.43

0.40

g/l

0.77

771

2078

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8124

40393

2.35

307.65

3.1

2.6

22.43

22.93

2.55

7738

37558

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13591

99207

1.63

307.65

4.7

3.2

33.49

33.00

u/l

0.33

12906

93837

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2399

7354

3.44

307.65

2.3

1.3

12.62

16.37

iu/ml

0.70

117

113

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1612

3672

4.56

307.65

1.3

1.2

29.37

11.67

u/ml

2.62

137

(3031040) Bacteria [#/volume] in Urine by Automated count

22459

185704

1.67

307.65

6.0

4.5

1385.29

1764.94

e6/l

0.33

243

2519

(3017732) Neutrophils [#/volume] in Blood

10657

33379

4.26

307.65

4.1

2.9

4.12

4.56

e9/l

6.16

9648

28874

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

3149

8226

4.13

307.65

1.4

1.2

39.57

38.41

u/ml

0.07

208

406

(3009261) Glucose [Presence] in Urine by Test strip

23949

152634

3.16

307.65

6.1

3.6

0.01

0.22

estimate

2.10

6107

28717

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

2050

5995

3.58

307.65

1.5

1.3

32.42

47.38

u/ml

1.13

(3021788) Differential panel - Synovial fluid

2952

3807

8.42

307.65

1.8

1.4

1.00

0.95

0.48

(3008757) Leukocyte morphology finding [Identifier] in Blood

951

2354

4.13

307.65

3.7

3.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2045

7146

2.98

307.65

5.0

1.8

0.00

g/l

0.14

1765

6312

(3007164) IgA [Mass/volume] in Serum or Plasma

10680

60801

2.12

307.65

2.2

1.4

2.49

2.33

g/l

10.26

7688

37490

(3027135) IgG subclass 1 [Mass/volume] in Serum

1069

2861

3.82

307.65

1.7

1.3

7.01

6.64

g/l

1.68

774

2081

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7977

49193

1.82

307.65

3.7

2.9

0.86

1.18

e6/l

4.65

4961

25162

(3030467) Casts [#/volume] in Urine by Automated count

12487

78187

1.97

307.65

4.4

3.2

0.31

0.41

e6/l

6.79

10024

55950

(3000494) Fungus identified in Specimen by Culture

5953

35030

1.85

307.65

1.7

1.5

—

(3017181) Myelocytes/Leukocytes in Blood

8792

22374

5.01

307.65

7.7

3.6

0.69

1.02

23.21

2704

6556

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

856

1917

4.55

307.65

2.3

2.1

14.86

14.58

0.28

834

1872

(3028026) IgM [Mass/volume] in Serum or Plasma

5948

15778

4.39

307.65

2.5

1.8

1.15

1.34

g/l

11.59

5561

14559

(3022145) Colonoscopy Study observation

7434

32103

2.70

307.65

2.0

1.3

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

1552

1673

9.68

307.65

1.9

1.3

38.39

27.24

17.16

1026

963

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1162

2144

5.58

307.65

1.3

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1146

168

70.58

307.65

1.8

1.6

119.19

184.85

au/ml

0.75

162

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2150

7447

3.02

307.65

4.9

1.8

0.03

0.02

g/l

0.39

1915

6749

(3004789) Transferrin [Mass/volume] in Serum or Plasma

8538

44241

2.26

307.65

3.0

2.6

2.32

2.37

g/l

11.19

8093

40887

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

11311

46797

3.17

307.65

1.6

1.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

18428

125098

2.09

307.65

9.9

6.5

1.22

1.21

mmol/l

9.33

17644

115960

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7433

44511

1.87

307.65

2.3

1.9

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

900

1154

7.98

307.65

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

3560

5181

7.58

307.65

2.1

1.4

8823.83

15315.17

e6/l

12.43

2738

3520

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1313

2446

5.54

307.65

1.3

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

1175

2196

5.51

307.65

1.3

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

7780

20144

4.76

307.65

5.0

2.3

10.64

10.50

g/l

1.59

7429

18541

(40761535) Cells panel - Urine sediment

3937

19518

2.15

307.65

5.9

3.1

0.80

1.55

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

393

45.13

307.65

3.3

2.4

—

(3006315) Basophils [#/volume] in Blood

30121

142199

16.57

307.65

18.7

4.8

0.04

e9/l

2.81

28613

121078

(1175426) CD3 cells/Lymphocytes in Blood

893

1990

4.58

307.65

2.4

2.1

73.70

72.40

1.47

856

1923

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

841

1733

4.95

307.65

1.8

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1982

8111

2.53

303.94

1.4

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

31648

297374

3.56

300.83

32.1

10.5

26.90

26.54

u/l

2.93

31525

289484

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2274

9968

2.37

299.98

2.1

2.0

2.27

2.22

ug/l

0.03

2051

8878

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5992

37064

1.75

299.42

9.6

6.0

1.05

1.04

mmol/l

0.16

5718

34571

(3019150) Specific gravity of Urine by Refractometry

9613

67394

1.60

296.23

6.7

3.7

1.16

kg/l

0.00

7188

43522

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4683

27250

1.84

286.35

3.1

2.3

0.22

0.21

g/l

11.90

4446

25492

(3020564) Creatinine [Moles/volume] in Serum or Plasma

31700

298816

3.59

286.25

37.7

18.2

75.68

75.32

umol/l

1.02

31614

295600

(3013166) Neutrophils/Leukocytes in Synovial fluid

404

534

7.64

285.56

1.8

1.2

46.60

58.57

6.33

362

440

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10641

77307

1.56

276.74

3.8

3.0

1236.85

1184.54

ng/l

0.55

9306

65785

(3019309) Folate [Moles/volume] in Red Blood Cells

6668

43276

1.68

276.67

1.9

1.7

1172.10

1164.43

nmol/l

0.28

5258

33071

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

15668

123768

1.51

275.37

2.3

2.1

93.98

97.49

pmol/l

18.75

9553

65051

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

486

835

5.89

267.69

1.9

1.8

9651.16

32241.99

u/ml

0.84

117

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

657

1478

4.51

265.79

2.2

1.2

6.04

5.78

u/l

0.35

583

1253

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1166

3872

3.08

265.71

1.7

1.4

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

376

506

7.50

261.62

1.5

1.2

41.95

40.10

0.32

277

315

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1025

3207

3.26

258.13

1.9

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1470

5712

2.64

249.81

1.5

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1796

7691

2.41

248.47

1.5

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

699

1741

4.08

247.43

2.4

2.7

0.64

0.69

e9/l

1.57

668

1678

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1359

5105

2.73

246.88

1.6

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1032

3334

3.16

246.31

2.0

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

19842

166644

1.49

244.20

7.0

5.0

6.51

6.65

mmol/l

19.70

19070

157401

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1156

4007

2.95

244.03

1.9

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1754

7518

2.41

242.03

1.8

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

12068

92392

1.48

234.37

3.4

2.7

61.05

69.03

u/l

0.60

11347

85736

(3020876) Protein [Mass/time] in 24 hour Urine

947

3015

3.20

231.53

3.7

2.2

0.86

1.38

g/24h

10.33

631

1761

(3025941) Bacteria identified in Stool by Culture

2980

16069

1.94

227.43

1.4

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

383

616

6.27

225.57

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

383

616

6.27

225.57

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

383

616

6.27

225.57

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

383

616

6.27

225.57

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1365

5446

2.57

219.36

1.7

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

4083

24560

1.76

218.45

12.1

7.6

9.44

9.32

mmol/l

0.51

3943

23563

(3026250) Tacrolimus [Mass/volume] in Blood

543

1229

4.47

217.90

45.6

42.1

6.90

7.37

ug/l

5.34

488

1124

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

861

2696

3.25

216.29

2.0

1.6

—

(3017704) Immunofixation for Urine

520

1151

4.57

214.60

2.8

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

1671

7406

2.32

213.08

3.2

3.1

2.58

2.23

index

0.52

809

3792

(44790047) Parainfluenza type 1 nucleic acid detection

1001

3474

2.94

210.57

2.0

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

1000

3470

2.94

210.41

2.0

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

1000

3471

2.94

210.30

2.0

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

1000

3473

2.94

210.08

2.0

1.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6877

47663

1.56

209.30

5.6

3.5

0.80

0.82

mmol/l

19.61

6555

44925

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

9659

71996

1.48

208.17

1.4

1.3

1.20

1.69

u/ml

5.92

2617

19897

(3016228) CD19 cells/cells in Blood

448

927

4.88

200.67

1.9

2.1

7.39

8.71

1.61

434

907

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

790

2457

3.27

200.60

2.1

1.7

—

(3006245) CD3-CD19+ cells/cells in Blood

490

1096

4.52

199.58

3.2

2.2

8.79

11.20

3.05

455

1031

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

862

2851

3.07

197.35

1.2

67.07

63.45

u/l

0.28

780

2487

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3559

21254

1.76

193.68

5.5

3.8

1.23

mmol/l

0.52

3276

18243

(3023103) Potassium [Moles/volume] in Serum or Plasma

30305

284758

1.95

191.33

25.6

17.3

3.94

3.96

mmol/l

39.83

29853

278913

(3019550) Sodium [Moles/volume] in Serum or Plasma

30257

284189

1.94

190.79

25.1

17.2

139.44

139.71

mmol/l

76.97

29853

278830

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3535

21220

1.74

188.58

5.4

3.9

83.44

87.80

ng/l

1.73

3175

18530

(3033658) Prothrombin time (PT) actual/Normal

9711

73711

1.45

185.66

6.1

4.1

91.80

91.36

1.05

9499

72043

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1291

5430

2.43

184.91

1.7

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6507

45610

1.53

184.81

4.1

3.0

2.70

3.10

e6/l

2.16

3464

21491

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

563

1489

3.82

183.15

2.5

2.9

42.78

38.31

5.32

321

806

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8707

64960

1.46

181.38

2.2

1.8

1.33

1.16

mg/l

3.79

6949

49965

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

587

1634

3.64

177.20

3.7

2.3

915.97

1026.11

u/ml

0.51

577

1619

(3016650) Hepatitis A virus Ab [Presence] in Serum

1194

4964

2.46

175.31

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

678

2085

3.30

175.28

1.5

1.2

76.83

81.26

0.78

117

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

451

1057

4.31

173.03

2.8

2.1

27.78

29.52

1.61

430

1013

(3000060) B lymphocytes [#/volume] in Blood

396

839

4.76

172.44

3.0

2.1

0.19

0.44

e9/l

1.34

191

411

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1795

8918

2.07

171.11

9.0

3.6

1.53

1.46

mg/l

3.06

1679

8215

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

237

312

7.63

168.12

1.7

1.6

—

(21494434) Karyotype in Bone marrow

672

2110

3.23

167.89

1.2

—

(40768797) Stomach Pathology biopsy report

5769

40198

1.53

166.09

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

240

334

7.22

162.11

1.2

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

339

664

5.14

161.89

2.3

3.5

2.15

1.75

ratio

3.16

318

600

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1893

9789

1.99

161.22

2.7

2.2

338.89

563.79

ug/l

2.66

1743

9260

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

588

1751

3.40

160.02

2.3

1.4

25.48

24.67

u/ml

0.15

179

267

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

356

736

4.87

159.65

1.9

2.1

2.20

1.63

ratio

5.62

342

712

(40768441) Liver Pathology biopsy report

637

1997

3.23

159.53

1.6

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

466

1201

3.92

157.25

1.1

3.26

3.83

iu/ml

0.75

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7665

57104

1.45

156.48

2.0

1.7

22715488.46

35773218.23

pmol/l

1.24

6696

47989

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5976

42487

1.50

154.88

3.2

2.1

29.56

29.54

0.07

5844

41328

(3005322) IgE [Units/volume] in Serum or Plasma

3306

20501

1.68

154.64

1.4

1.3

369.66

220.30

u/ml

3.63

3108

19116

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

753

2659

2.87

153.20

1.9

1.2

61.61

57.12

u/ml

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

890

3467

2.61

149.68

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1142

4998

2.33

149.15

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7336

54818

1.43

145.51

2.9

3.0

2.45

mmol/l

8.04

6676

49160

(3044927) Protein electrophoresis panel - Urine

652

2196

3.01

144.45

1.3

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4043

26845

1.58

142.47

3.6

3.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

3511

22563

1.62

141.93

3.2

2.7

67.73

68.51

ml/min/173m2

0.51

1534

9360

(3036670) Protein [Mass/volume] in Synovial fluid

315

652

4.86

141.09

1.4

1.2

40.32

39.91

g/l

0.16

188

319

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

632

2133

3.00

139.50

1.9

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

632

2133

3.00

139.50

1.9

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

632

2133

3.00

139.50

1.9

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

353

812

4.38

138.78

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

222

336

6.64

138.78

1.9

2.8

—

(3007916) DNA double strand Ab [Titer] in Serum

193

255

7.60

136.52

1.6

1.2

121.67

172.99

titre

0.23

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12627

104306

1.34

132.81

4.3

3.5

105.97

53.66

ng/l

0.72

8794

67805

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

15835

135222

1.33

132.53

3.4

2.7

—

estimate

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

150

10.03

132.22

1.1

32.03

32.63

u/ml

0.02

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

150

10.03

132.22

1.1

23.49

24.61

u/ml

0.06

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

501

1523

3.32

131.93

1.5

1.2

97.02

68.45

titre

0.44

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

182

234

7.81

131.80

1.5

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

514

1592

3.26

131.31

1.3

1.2

22.41

24.70

u/l

0.41

444

1334

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

521

1629

3.23

131.04

1.3

1.2

79.31

94.39

u/l

2.39

455

1392

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

246

438

5.64

130.57

7.1

6.5

1899.00

4425.00

iu/ml

0.82

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

507

1564

3.27

130.38

1.6

1.2

402.00

600.51

titre

0.54

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4867

34241

1.49

130.20

4.1

2.7

7.18

8.28

umol/l

3.41

4266

29824

(3042631) Mycobacterium sp identified in Specimen

805

3207

2.54

129.17

2.9

2.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

855

3511

2.47

128.63

1.6

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1048

4716

2.26

128.00

1.3

1.2

4.53

3.36

u/ml

1.00

471

1761

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

866

3598

2.44

127.01

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

852

3523

2.45

126.26

1.6

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

468

1423

3.32

123.21

1.3

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

801

3257

2.49

123.07

2.2

32.89

32.39

2.47

791

3237

(3037121) Protein [Mass/volume] in Urine

1693

9258

1.87

121.14

4.1

3.4

337.45

500.54

mg/l

2.22

895

4253

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2597

16068

1.67

121.00

1.9

1.7

—

(40768446) Kidney Pathology biopsy report

399

1108

3.63

120.91

2.0

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

495

1576

3.17

120.82

1.6

1.5

6.28

7.00

u/l

0.48

408

1236

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

147

163

9.04

120.02

4.3

2.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2895

18484

1.62

118.95

6.1

3.7

5.06

5.15

kpa

7.40

2800

17665

(21491868) Cryoglobulin [Mass/volume] in Serum

359

944

3.83

117.81

1.3

1.2

0.57

0.29

g/l

0.64

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4067

28117

1.51

117.34

7.2

4.0

5.78

5.82

kpa

1.88

3966

27467

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

22.08

116.86

8.1

3.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

790

3311

2.42

113.61

2.6

2.5

23.74

26.77

iu/ml

0.31

322

(3012544) pH of Venous blood

4087

28465

1.50

113.45

7.3

4.0

7.38

0.36

2372

16229

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

548

1923

2.88

112.75

1.7

1.4

—

(3009343) pH of Capillary blood

2803

17984

1.61

112.58

6.2

3.7

7.42

3.73

2359

14926

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

798

3375

2.40

112.46

1.6

1.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

102

14.19

112.19

5.8

2.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

104

13.71

112.16

6.1

2.5

365924.67

117071.39

u/ml

0.36

(3005988) Vibrio sp identified in Specimen by Organism specific culture

797

3380

2.39

111.63

1.6

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

992

4616

2.18

111.47

1.3

1.2

4.16

3.97

u/ml

0.19

490

2164

(3025468) Yersinia sp identified in Specimen by Organism specific culture

794

3366

2.39

111.30

1.6

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

472

1535

3.10

111.15

1.7

1.4

—

(3002032) Base excess in Venous blood by calculation

3929

27408

1.49

107.77

7.3

4.0

1.73

1.77

mmol/l

0.21

3486

24183

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

909

4149

2.22

107.13

1.1

1.52

1.49

g/l

1.20

863

3792

(3006922) Hepatitis E virus Ab [Presence] in Serum

613

2344

2.64

106.95

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

122

123

9.94

106.93

4.1

1.5

—

(3000012) Reticulocyte production index

797

3450

2.34

106.53

2.1

2.2

0.92

0.90

0.43

599

2284

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

583

2181

2.70

106.23

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

622

2411

2.61

105.57

1.2

1.1

47.49

41.86

mg/l

1.62

520

2054

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

115

109

10.57

105.28

9.9

2.6

—

(3042733) HLA Ab [Presence] in Serum

344

951

3.64

104.98

4.5

5.1

—

(3007461) Platelets [#/volume] in Blood

31733

308292

2.27

103.93

48.5

21.7

263.79

254.24

e9/l

121.67

31549

302200

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

602

2317

2.62

103.66

1.1

—

(3010421) pH of Blood

1529

8496

1.84

103.65

4.4

3.5

7.41

0.56

1515

8375

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

601

2326

2.61

102.33

1.1

251.66

265.30

mg/l

0.62

524

2074

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

442

1452

3.07

102.31

1.7

1.4

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

31733

308400

2.25

101.99

48.2

21.6

92.62

90.69

307.65

31659

305507

(3035941) MCH [Entitic mass]

31733

308400

2.25

101.99

48.1

21.6

30.69

30.23

307.65

31660

305510

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

406

1272

3.22

101.83

1.1

217.53

210.28

iu/ml

0.12

400

1264

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

31733

308420

2.25

101.64

49.1

22.1

40.21

41.06

20.33

31660

305408

(3026361) Erythrocytes [#/volume] in Blood

31733

308431

2.25

101.44

48.3

21.6

4.38

4.52

e12/l

307.65

31482

301392

(3010813) Leukocytes [#/volume] in Blood

31735

308474

2.25

101.16

48.4

21.7

6.80

6.68

e9/l

19.65

31491

301417

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

427

1388

3.10

100.66

1.8

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

31733

308495

2.24

100.30

48.7

21.8

133.37

135.90

g/l

197.67

31662

305663

(3023419) Bacteria identified in Sputum by Culture

754

3317

2.30

97.05

2.4

2.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8757

70972

1.32

96.73

3.1

2.4

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

144

202

7.15

96.67

4.4

4.2

2.13

2.17

mg/l

0.07

114

182

(3027801) Oxygen [Partial pressure] in Arterial blood

4387

31879

1.43

96.34

9.4

8.0

12.30

12.73

kpa

6.08

4232

30747

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4388

31894

1.43

96.22

9.5

8.0

5.03

5.10

kpa

5.92

4229

30776

(3045142) Bone marrow Pathology biopsy report

687

2914

2.38

96.16

1.3

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

337

975

3.48

96.03

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2596

16976

1.57

95.43

8.3

4.2

24.16

24.24

mmol/l

0.65

2575

16792

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1595

9198

1.77

95.36

4.7

2.6

3.52

3.56

g/l

0.57

1532

8819

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

208

423

4.94

95.25

1.7

1.3

273410.94

14238.33

u/ml

0.47

(4268621) Lupus anticoagulant assay

747

3310

2.28

94.52

2.4

2.3

—

(3019977) pH of Arterial blood

4380

31937

1.43

94.19

9.5

8.0

7.42

5.97

2404

17094

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2438

15758

1.59

94.18

6.2

3.6

1.58

1.69

mmol/l

0.77

1825

11606

(4027681) Cerebrospinal fluid IgG ratio and IgG index

491

1808

2.74

92.29

1.3

1.2

0.73

0.64

ratio

1.20

294

1034

(3048879) Bone marrow aspiration report

241

568

4.26

91.94

2.0

1.8

2.00

—

(3016502) Oxygen saturation in Arterial blood

3945

28340

1.44

91.84

9.8

8.4

95.57

95.77

1.20

3825

27389

(3003396) Base excess in Arterial blood by calculation

4330

31676

1.42

91.16

9.4

7.9

0.90

mmol/l

0.00

3647

26308

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1637

9633

1.73

91.08

4.5

2.3

94.86

93.57

1.50

1593

9273

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

453

1613

2.83

90.76

1.2

1.1

1.09

1.15

u/l

0.67

202

652

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

172

310

5.56

90.22

10.7

9.4

0.51

0.37

umol/l

1.03

126

296

(3014765) Yersinia sp identified in Stool by Organism specific culture

1384

7827

1.80

88.30

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

386

1278

3.04

88.19

2.1

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1363

7677

1.81

88.15

1.9

1.3

544.07

530.32

mg/l

0.15

1323

7350

(3028433) Virus identified in Specimen by Culture

285

782

3.66

88.02

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1385

7844

1.80

87.93

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

227

530

4.30

87.69

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

384

1277

3.03

87.07

2.1

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

384

1277

3.03

87.07

2.1

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

384

1277

3.03

87.07

2.1

1.8

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1021

5264

1.97

86.87

2.0

1.9

4.89

5.20

mmol/24h

2.33

935

4722

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

683

3024

2.28

86.59

1.1

53.50

64.55

au/ml

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3575

25495

1.45

86.13

10.7

7.9

1.30

1.33

mmol/l

0.63

3505

25044

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

696

3113

2.26

86.12

1.1

28.92

21.29

au/ml

—

(3024932) HLA-DR beta [Type]

300

866

3.48

85.83

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

339

1057

3.23

85.77

3.3

1.11

1.41

2.29

339

1057

(3019225) pH of Specimen

3596

25693

1.45

85.74

6.1

4.0

7.36

1.45

3030

18150

(3024471) HLA-A [Type]

304

886

3.45

85.69

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1367

7796

1.78

84.74

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

110

132

8.35

84.43

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3877

28182

1.42

84.01

3.0

2.6

41.18

49.23

u/l

0.79

3392

23870

(3033099) Centromere Ab [Titer] in Serum

257

679

3.80

83.89

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

196

424

4.64

83.39

1.2

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1223

6833

1.82

81.15

1.9

1.2

3.63

3.74

mmol/l

2.81

1163

6473

(3020961) Endomysium IgA Ab [Titer] in Serum

2286

15064

1.55

80.69

1.1

170.63

191.31

titre

0.13

418

(37208534) Antinuclear antibody arbitrary concentration in serum

313

969

3.25

80.15

1.2

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

3310

23566

1.45

80.06

6.6

3.4

4.67

4.61

kpa

0.86

3215

22981

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1576

9540

1.68

78.81

4.4

2.8

24.43

24.72

mmol/l

2.40

1555

9366

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

298

905

3.31

78.74

2.3

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

298

905

3.31

78.74

2.3

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

368

1267

2.92

78.49

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

368

1267

2.92

78.49

1.5

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

300

919

3.28

78.17

2.3

2.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2810

19470

1.48

78.11

13.5

8.3

24.80

24.81

mmol/l

0.04

2793

19335

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1682

10396

1.65

77.59

2.4

2.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

583

2530

2.32

77.48

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

307

965

3.20

76.69

2.9

2.8

0.60

0.61

mmol/l

1.91

307

965

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1490

8955

1.69

76.50

4.2

2.5

201.95

186.65

8.77

1424

8518

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1193

6746

1.80

76.01

2.1

1.4

37.96

33.92

e6/l

0.11

896

4976

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1205

6836

1.79

75.94

2.2

1.4

1215.35

2439.30

e6/l

0.78

959

5361

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

767

3756

2.06

75.35

7.6

6.2

11.82

11.58

mg/l

0.73

722

3489

(3036489) Thrombin time

1798

11388

1.61

75.09

3.7

2.1

21.32

20.93

1.42

1618

10020

(3013727) Leukocytes other/Leukocytes in Blood

252

710

3.56

74.88

3.9

3.2

52.23

52.51

0.07

243

690

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1163

6589

1.79

73.60

2.7

2.2

127.33

130.96

g/l

4.97

791

5152

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3625

26683

1.40

72.29

10.5

8.8

118.42

121.77

g/l

19.41

3558

26084

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

167

357

4.69

72.15

2.1

2.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1543

9535

1.65

71.11

2.1

1.8

—

(4035726) Immunohistochemistry procedure

3380

24661

1.41

70.85

1.5

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

435

1726

2.54

70.45

1.2

1.1

1.08

1.06

ratio

1.16

381

1419

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

355

1275

2.80

70.08

1.2

25.39

8.83

u/ml

0.78

138

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

226

620

3.66

69.92

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1258

7398

1.73

69.88

7.4

3.6

8.64

8.48

kpa

2.05

1237

7214

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

487

2047

2.40

69.63

1.2

—

(3036603) Volume of Urine

493

2090

2.38

69.15

2.3

1.5

1967.59

1990.37

0.22

487

2045

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1015

5634

1.82

68.72

4.2

3.3

8.01

8.99

pmol/l

2.33

1015

5628

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

481

2024

2.39

68.61

1.2

—

(1616796) Gas panel - Central venous blood

1076

6088

1.79

68.37

4.8

3.6

—

(3042951) Complement C1q Ab [Units/volume] in Serum

8.68

67.38

1.5

1.1

21.54

18.89

u/ml

0.16

(3001729) Color of Synovial fluid

100

140

7.15

67.33

2.5

1.2

—

(3020891) Body temperature

1911

12599

1.55

66.92

4.9

4.7

36.92

36.91

°c

0.82

1892

12492

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

147

301

4.89

66.90

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

398

1559

2.57

66.23

1.2

1.1

76.01

83.87

u/l

1.17

375

1378

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

396

1549

2.57

66.09

1.2

1.1

21.93

23.37

u/l

0.17

374

1368

(3032352) Blasts [#/volume] in Cerebral spinal fluid

139

275

5.06

65.84

4.9

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

286

957

3.00

64.27

4.7

1.4

40.16

40.36

g/l

0.23

286

957

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1370

8442

1.65

63.75

5.1

3.2

0.34

0.35

iu/ml

1.14

726

4616

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2782

20039

1.42

62.26

3.6

2.9

172.94

178.11

ng/l

0.26

2539

18282

(3014007) Fractional oxyhemoglobin in Arterial blood

2582

18359

1.44

62.06

12.2

10.1

93.87

94.06

0.80

2576

18298

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

528

2414

2.20

61.99

3.7

3.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

398

1617

2.48

61.36

1.6

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

402

1641

2.46

61.34

1.6

1.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

111

191

5.82

61.25

1.0

1.1

4.21

5.28

u/ml

—

(36660697) Celiac disease serology panel - Serum

3393

25357

1.38

61.05

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2240

15576

1.47

60.50

1.1

11.67

10.05

u/ml

0.08

170

(3021901) Oxygen saturation in Capillary blood

977

5577

1.77

60.20

4.3

2.9

90.61

90.52

0.18

961

5418

(3001964) Herpes simplex virus Ag [Presence] in Specimen

241

759

3.19

60.12

1.7

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

980

5632

1.76

58.99

3.2

2.6

16.28

16.66

3.70

962

5503

(3026389) Candida sp identified in Specimen by Organism specific culture

807

4385

1.86

58.50

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

408

1714

2.39

58.47

1.6

1.5

17.25

24.47

umol/l

7.48

390

1587

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2549

18292

1.42

58.07

12.1

10.0

1.27

1.33

3.41

2529

18190

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

311

1162

2.69

56.99

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

311

1162

2.69

56.99

1.6

1.4

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

117

7.19

56.85

2.8

1.2

0.44

0.82

0.80

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

462

2084

2.23

56.11

1.2

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

966

5610

1.74

56.04

4.9

3.8

8.71

8.72

kpa

0.08

951

5480

(40758292) HTLV I+II Ab panel - Serum

177

481

3.69

55.63

1.6

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

361

1471

2.47

55.35

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2692

36108

0.72

54.75

1.8

1.9

3.47

3.49

ratio

0.43

2078

27416

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

919

5297

1.75

54.75

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

919

5297

1.75

54.75

1.4

1.3

—

(3013290) Carbon dioxide [Partial pressure] in Blood

954

5580

1.73

53.95

5.0

3.8

4.92

5.02

kpa

4.63

939

5451

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2456

17741

1.41

53.75

12.5

10.3

0.66

0.64

2.21

2440

17651

(3012501) Base excess in Blood by calculation

953

5579

1.73

53.73

4.9

3.8

2.33

2.49

mmol/l

1.12

685

3745

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

170

464

3.67

53.11

3.0

2.7

48.18

42.05

mg/l

0.17

122

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2319

16638

1.42

52.70

12.5

10.0

24.33

24.28

mmol/l

0.29

2267

16323

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

24073

227186

1.23

52.42

4.6

4.5

14.89

14.68

pmol/l

36.97

22488

210570

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

498

2381

2.11

52.23

1.1

286.59

411.85

mg/l

0.51

469

2170

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1914

27000

0.69

52.12

1.5

1.7

3.40

3.49

mmol/l

2.96

1284

18261

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

823

4665

1.78

51.94

1.2

0.97

1.07

0.14

209

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1533

10170

1.53

51.91

7.0

3.9

24.62

24.80

mmol/l

1.95

1443

9443

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2303

16613

1.41

50.69

7.1

7.0

24.52

24.53

mmol/l

0.09

2215

15919

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2043

14427

1.44

50.60

5.3

3.1

0.65

0.62

3.54

2035

14385

(3022621) pH of Urine by Test strip

3052

23075

1.35

50.42

3.3

2.4

6.04

6.08

2.42

1992

15046

(3020393) Adenovirus Ag [Presence] in Stool

133

318

4.19

50.00

2.2

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

27620

265106

1.27

48.89

5.6

5.5

1.85

1.87

mu/l

1.90

26087

248026

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

146

381

3.84

48.71

1.8

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2046

14559

1.43

48.55

5.3

3.1

1.21

1.28

3.22

2033

14497

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

158

437

3.62

48.45

1.4

1.0

40.03

2.38

iu/ml

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

185

569

3.26

48.10

1.2

47.30

17.14

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

244

882

2.78

47.76

1.1

2.46

6.38

u/ml

1.47

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

139

358

3.89

47.26

1.3

1.6

54552.92

266785.61

nmol/l

1.29

110

298

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

284

1116

2.55

47.10

4.3

4.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6400

53653

1.24

47.04

4.5

3.8

326.13

458.10

ng/l

1.77

4835

39672

(3012565) Volume of 24 hour Urine

318

1321

2.42

46.83

3.1

2.0

2016.82

1982.08

0.24

296

1185

(3008536) Aspergillus sp Ab [Presence] in Serum

175

533

3.29

46.25

2.2

2.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

197

648

3.05

45.78

1.1

7.16

6.80

mg/g

0.28

188

616

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

185

588

3.15

45.58

1.2

1.1

—

(3044889) 12 lead EKG panel

21042

196992

1.19

45.54

4.4

3.9

0.42

3109.75

1.34

383

(3023410) Appearance of Cerebral spinal fluid

584

3109

1.89

45.19

2.9

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

118

287

4.12

43.43

1.7

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

330

1442

2.30

43.36

2.4

1.9

2.05

1.92

umol/l

1.65

316

1322

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

378

1747

2.17

43.34

1.4

13.67

12.56

u/l

1.56

366

1695

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

480

2426

1.99

43.33

1.2

106.42

112.59

pmol/l

1.89

480

2426

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

213

4.65

42.61

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

719

4163

1.74

42.19

2.2

1.8

1.67

1.73

mmol/l

1.10

702

4051

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

237

907

2.62

41.56

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1319

8885

1.50

41.44

1.5

1.4

285.17

276.66

ug/g

0.77

759

5107

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2796

21452

1.33

41.44

2.3

8.49

7.31

ug/l

1.06

2465

18928

(3013512) EKG study

10590

94066

1.18

41.37

3.7

3.5

0.77

0.74

0.13

227

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

108

257

4.21

40.94

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

741

4372

1.71

40.64

1.1

3.44

2.76

1.01

785

(3004119) Hemoglobin [Mass/volume] in Venous blood

2277

17019

1.36

40.13

5.8

3.4

125.33

130.14

g/l

19.96

2212

16565

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

553

3022

1.84

39.47

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

135

388

3.48

39.17

6.2

5.2

40.87

41.43

ug/min

0.04

110

292

(3051611) Lipemic interference index of Serum or Plasma

499

2665

1.88

38.30

4.3

3.4

16.20

14.19

index

1.45

333

1500

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1831

13332

1.39

37.87

4.9

4.0

49.33

48.31

1.01

1795

13168

(3018405) Lactate [Moles/volume] in Arterial blood

1253

8511

1.49

37.78

3.9

4.3

1.33

1.38

mmol/l

1.04

1228

8349

(3004716) Salmonella sp identified in Stool by Organism specific culture

2008

14865

1.37

37.53

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

221

862

2.57

37.34

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

275

1188

2.32

37.19

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

380

1871

2.04

36.98

3.7

2.2

100.45

98.12

0.58

368

1752

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2144

16123

1.35

36.21

13.0

10.0

15.58

16.14

17.57

2079

15579

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1208

8230

1.48

35.88

1.2

4.45

3.87

1.01

117

1222

(3022806) Fractional oxyhemoglobin in Capillary blood

559

3159

1.78

35.75

1.9

1.8

90.18

90.00

0.38

547

3108

(3012516) Albumin [Mass/volume] in Urine

10141

90555

1.17

35.72

4.1

3.5

50.97

46.70

mg/l

1.16

6843

56901

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

309

1437

2.16

34.99

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

522

2922

1.80

34.49

1.4

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

336

1630

2.07

34.09

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

21323

201800

1.16

33.46

4.3

3.3

50.30

45.73

u/l

10.01

20361

190997

(3009508) Creatinine [Moles/volume] in Urine

11032

99578

1.16

33.11

4.1

3.5

7.44

7.66

mmol/l

5.35

9620

85003

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.25

32.78

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

720

4478

1.62

32.28

1.1

120.53

117.77

1.37

677

4067

(3003181) Sodium [Moles/volume] in Urine

784

4983

1.59

32.10

1.6

1.5

62.53

62.47

mmol/l

0.01

626

3952

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1165

8064

1.46

31.91

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1454

10501

1.40

31.49

1.3

219.34

221.10

miu/ml

0.06

545

4921

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

144

496

2.91

31.02

1.4

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

10214

91999

1.16

30.96

4.8

4.2

11.17

8.21

mg/mmol

1.06

6735

56605

(3029634) Reagin Ab [Titer] in Serum by VDRL

702

4386

1.61

30.90

1.9

2.3

6.33

9.70

titre

0.31

120

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

218

924

2.37

30.90

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

734

4646

1.59

30.61

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

435

2392

1.83

30.54

3.1

2.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

240

1067

2.26

30.45

1.1

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

114

350

3.26

29.93

1.4

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1605

11922

1.36

29.25

4.7

3.5

25.18

25.27

mmol/l

0.46

1551

11528

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

397

2157

1.85

29.00

1.4

12.86

12.19

umol/l

1.14

388

2031

(3011325) HIV 1+2 Ab [Presence] in Serum

110

5.27

29.00

1.1

0.08

0.86

(4195642) Thrombophilia screening test

699

4431

1.59

28.98

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

565

3402

1.67

28.84

1.1

97.40

96.60

0.29

535

3205

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

170

667

2.55

28.52

1.6

1.9

21.06

40.68

u/l

2.31

147

606

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

424

2369

1.80

28.29

1.3

2.15

2.08

mmol/l

0.29

398

2203

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

179

726

2.47

28.01

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

175

710

2.47

27.38

1.2

1.1

—

(3003129) Base excess in Capillary blood by calculation

540

3258

1.67

27.37

2.8

2.1

0.48

0.56

mmol/l

0.19

519

3115

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

146

543

2.69

27.30

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

2502

31022

0.79

27.18

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

1029

7180

1.45

27.03

4.1

4.6

3.86

3.87

mmol/l

0.13

1018

7124

(3002621) Streptococcal DNAse B [Units/volume] in Serum

278

3.42

26.96

1.1

216.81

312.67

u/ml

1.30

(3028679) Herpes simplex virus Ab [Presence] in Serum

328

1721

1.91

26.75

1.1

1.2

—

(3034426) Prothrombin time (PT)

207

916

2.26

26.63

1.2

27.86

28.19

0.37

207

916

(40765096) Chromosome analysis panel by Banding

182

765

2.38

26.37

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

531

3223

1.66

26.32

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

258

1253

2.06

26.24

3.7

4.7

1994.88

2100.85

mg/l

0.03

214

911

(3009015) Lactate [Moles/volume] in Synovial fluid

255

3.45

25.38

1.4

1.2

5.41

6.27

mmol/l

0.81

121

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

436

2562

1.71

24.46

1.8

1.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

260

1302

2.00

24.35

5.3

2.1

49.49

226.53

ug/l

1.27

253

1238

(3010937) Rubella virus Ab [Presence] in Serum

175

3.94

24.18

1.1

—

(3045716) Anion gap in Serum or Plasma by calculation

479

2901

1.66

23.99

3.2

3.1

10.36

10.84

mmol/l

1.99

473

2859

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2784

22801

1.24

23.96

1.6

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

257

1291

2.00

23.87

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

1736

13489

1.30

23.12

3.8

3.2

1.02

ratio

1.03

1583

12052

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

320

1748

1.84

23.10

1.3

18.83

14.23

u/l

1.11

300

1612

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

227

1106

2.06

22.96

1.2

908.70

1030.25

titre

0.71

238

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1583

12165

1.31

22.87

5.5

4.9

1.59

1.66

1.99

1509

11537

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

701

4698

1.50

22.67

1.3

45.08

30.26

u/l

2.83

639

4082

(3036048) Francisella tularensis Ab [Titer] in Serum

153

646

2.37

22.04

1.2

1.1

704.00

564.71

titre

—

(3017569) Oxygen content in Arterial blood

262

1366

1.92

21.89

2.2

2.3

15.88

16.00

0.24

262

1366

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

317

1757

1.81

21.85

1.2

1.1

10.53

4.47

nmol/l

1.63

101

285

(3024928) Oxygen saturation in Venous blood

1000

7215

1.40

21.82

7.0

3.4

63.36

62.66

0.47

975

6980

(4024509) Urine culture

1644

12805

1.30

21.49

2.1

1.9

—

(3018133) Calcium [Moles/volume] in Urine

150

637

2.36

21.35

1.7

2.2

2.60

2.73

mmol/l

0.31

135

581

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

134

4.18

21.26

3.3

5.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

166

739

2.25

21.17

1.7

1.6

0.33

0.41

ug/l

2.48

134

533

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

359

2083

1.73

21.17

1.3

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

567

3692

1.54

21.03

1.5

1.9

12977.78

3212.99

titre

—

154

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

229

3.32

20.71

1.2

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

27173

264443

1.16

20.63

6.4

6.1

38.17

38.91

mmol/mol

40.30

25932

249238

(3023183) Ammonium ion [Moles/volume] in Plasma

874

6223

1.41

20.61

2.9

2.8

32.85

34.08

umol/l

0.79

811

5634

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

111

417

2.66

20.49

2.0

1.2

790.62

109.27

ng/l

0.46

266

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

289

1599

1.81

20.09

1.4

1.6

1709517.80

2290171.23

iu/ml

—

115

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

238

1241

1.92

19.93

1.2

1.1

292.66

502.88

ng/l

0.59

332

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

104

384

2.71

19.87

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3680

31531

1.19

19.69

8.0

6.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4040

34921

1.18

19.46

2.0

2.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

110

4.36

19.29

1.4

—

(3047181) Lactate [Moles/volume] in Blood

1095

8185

1.35

19.18

6.0

5.7

1.31

mmol/l

0.00

963

7268

(3016038) Potassium [Moles/volume] in Urine

320

1853

1.73

19.06

1.4

1.3

31.83

34.11

mmol/l

1.07

277

1629

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

270

1494

1.81

18.80

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4362

38038

1.17

18.77

2.1

2.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

506

3309

1.54

18.47

1.5

1.4

34.23

42.67

g/l

0.45

474

3017

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

332

2.77

18.40

1.2

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

370

2253

1.65

18.28

1.4

1.3

531.20

475.20

u/l

0.45

349

2141

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1659

13208

1.27

18.22

1.6

1.8

0.28

0.31

mg/l

1.54

749

6335

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

261

1446

1.81

18.12

1.3

59.97

64.60

0.31

166

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

251

3.03

17.85

1.6

0.97

1.86

mg/l

1.24

177

(40761539) Cells [Type] in Urine sediment by Light microscopy

139

619

2.25

17.81

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

294

2.86

17.80

1.3

1.2

1.20

1.84

iu/ml

3.37

156

(3036782) Glucose [Moles/volume] in Pleural fluid

388

2408

1.62

17.78

1.4

1.3

5.78

6.34

mmol/l

3.56

357

2243

(3046861) Legionella sp Ag [Presence] in Urine

146

3.70

17.40

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

872

11734

0.73

17.36

1.1

0.57

0.63

ratio

2.98

112

1390

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

932

12415

0.74

17.33

1.1

1.52

g/l

0.15

932

12403

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

245

3.02

17.32

1.6

2.69

2.68

mg/l

0.00

177

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

245

3.02

17.32

1.6

1.64

1.11

mg/l

0.31

160

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

245

3.02

17.32

1.6

0.95

2.24

mg/l

2.81

192

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

245

3.02

17.32

1.6

4.30

3.96

mg/l

0.12

167

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

245

3.02

17.32

1.6

0.42

1.04

mg/l

2.29

176

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

245

3.02

17.32

1.6

1.65

2.25

mg/l

0.38

171

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

245

3.02

17.32

1.6

1.71

2.54

mg/l

0.80

184

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

246

3.01

17.20

1.6

1.75

1.67

mg/l

0.05

164

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

246

3.01

17.20

1.6

1.37

1.69

mg/l

0.44

186

(3032057) Clostridioides difficile [Presence] in Stool

115

482

2.39

16.97

2.0

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1407

11076

1.28

16.95

5.9

5.2

0.86

0.89

1.45

1338

10482

(3001186) Copper [Moles/volume] in Serum or Plasma

171

852

2.01

16.44

1.2

1.3

16.55

16.70

umol/l

0.12

158

735

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

330

2.67

16.40

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

112

474

2.36

16.20

1.2

1.4

8.60

380.96

titre

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.35

16.05

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

339

2089

1.63

16.05

3.3

3.1

23.50

25.82

mu/l

0.53

325

1966

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

242

2.93

15.83

1.2

0.25

0.60

iu/ml

4.15

129

(3002256) Pathology report gross observation

4413

38975

1.15

15.79

1.3

—

(4034850) Laboratory test

1104

8508

1.31

15.68

13.0

9.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3691

32191

1.16

15.67

1.7

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

451

2985

1.52

15.65

1.5

1.4

2949.77

3707.97

e6/l

0.52

308

2087

(3022229) Phosphate [Moles/volume] in Urine

213

3.05

15.53

1.8

2.5

20.01

18.77

mmol/l

0.15

181

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

112

3.93

15.47

2.0

1.3

—

(44806071) Cardiolipin IgM antibody measurement

401

2.44

15.30

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

142

679

2.09

15.30

1.2

6.84

12.01

pmol/l

3.71

255

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

747

5459

1.38

15.21

1.1

19.01

15.04

au/ml

0.68

156

1430

(3004451) EKG impression Narrative

247

1427

1.73

14.96

1.4

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

173

3.24

14.78

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

139

3.52

14.77

3.4

3.6

—

(3045462) Protein/Creatinine [Ratio] in Urine

408

2.40

14.75

7.7

4.6

513.42

59.68

mg/mmol

0.48

368

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

776

5745

1.36

14.57

3.4

3.6

322.67

944.99

u/ml

2.82

693

5218

(3016750) Collection duration of Urine

244

1416

1.73

14.56

2.7

2.2

504.94

497.21

min

0.56

192

1073

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1070

8299

1.30

14.51

1.1

5.35

6.04

eliau/ml

0.16

1140

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

244

1425

1.72

14.25

1.3

1.2

13.14

9.47

mm/h

3.17

244

1425

(3007919) Fasciola sp Ab [Titer] in Serum

5.51

14.24

1.1

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

140

685

2.05

14.22

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

362

2342

1.55

14.01

2.0

1.8

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

107

3.83

13.95

3.8

4.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

238

1392

1.71

13.84

1.8

1.7

1.50

2.68

u/field

3.11

163

1004

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1180

14785

0.79

13.79

1.5

1.6

1012.10

1015.65

mu/l

0.04

952

12450

(3019174) dRVVT (LA screen)

241

2.78

13.61

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

290

1799

1.62

13.46

1.5

1.6

7.76

8.72

ug/l

0.30

263

1654

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

414

2.32

13.40

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

249

2.73

13.36

1.2

—

(3035880) pH of Pleural fluid

213

1223

1.74

13.26

1.3

7.38

7.41

1.18

147

855

(3050129) First trimester maternal screen panel - Serum or Plasma

742

9820

0.75

13.25

1.5

—

(3002619) Bacteria identified in Specimen by Culture

146

746

1.96

13.18

1.4

1.2

—

(40768806) Pleura Pathology biopsy report

375

2482

1.51

13.11

1.6

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

453

3117

1.46

13.06

4.0

7.8

7.25

7.34

mmol/l

0.17

386

2582

(40757373) Influenza virus identified in Isolate

103

463

2.23

13.05

2.0

1.6

—

(3045788) Cell count panel - Pleural fluid

366

2418

1.52

12.91

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

332

5022

0.66

12.91

2.6

3.9

24.29

39.49

u/ml

4.08

321

4849

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

173

943

1.84

12.84

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

121

584

2.07

12.81

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

163

3.13

12.78

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

121

585

2.07

12.75

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

121

585

2.07

12.75

1.2

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

28508

279947

1.14

12.70

5.2

5.0

4.60

4.68

mmol/l

42.44

27072

264440

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.75

12.68

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2991

34080

0.86

12.55

1.7

—

6.70

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

242

2.69

12.40

1.1

20.60

22.01

u/l

0.27

158

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

721

1.94

12.38

1.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

3.77

12.37

1.1

—

(3039000) Anion gap in Blood by calculation

737

5555

1.33

12.36

7.3

6.8

11.25

11.26

mmol/l

0.04

671

5017

(3018572) Chloride [Moles/volume] in Blood

737

5556

1.33

12.34

7.3

6.8

105.00

105.13

mmol/l

0.31

671

5019

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

133

674

1.97

12.33

1.8

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

100

455

2.20

12.33

1.5

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

580

7864

0.73

12.23

1.4

1.5

1.15

1.19

ratio

0.50

330

4733

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

580

7863

0.73

12.22

1.4

1.5

0.94

0.95

ratio

0.17

326

4695

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

578

7835

0.73

12.17

1.4

1.5

1.21

1.16

ratio

0.47

324

4668

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

5.99

12.08

5.0

5.6

165.87

3862.25

e6/l

0.57

(4015189) Microbial culture of sputum

122

607

2.01

11.93

1.8

2.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

572

7740

0.73

11.91

1.4

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

465

3276

1.42

11.85

2.4

1.9

26.97

24.67

mg/l

0.43

191

1192

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.65

11.83

1.2

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

140

3.21

11.82

8.0

10.9

394.91

248.51

e6/l

0.24

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1513

12520

1.22

11.72

2.2

2.4

6596.32

5655.19

u/l

0.37

486

4918

(3028308) Erythrocytes [#/volume] in Pleural fluid

389

2662

1.46

11.60

1.5

1.4

47664.96

51821.51

e6/l

0.12

207

1494

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

269

2.53

11.52

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

302

4541

0.66

11.46

4.8

5.7

349.92

369.55

umol/l

1.76

258

4011

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

372

2.26

11.10

1.2

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

28779

283134

1.13

11.03

5.7

5.6

2.66

2.76

mmol/l

83.54

27229

266436

(3024316) Viscosity of Plasma

122

3.28

10.87

1.3

1.7

1.64

1.53

mpas

0.40

(3027035) Albumin [Mass/time] in 24 hour Urine

231

2.60

10.77

1.8

1.3

213.50

296.78

mg/24h

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

563

4165

1.36

10.76

3.3

2.1

10.34

6.93

umol/l

2.41

423

3059

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1036

12801

0.80

10.75

1.2

0.87

0.89

g/l

1.66

1036

12762

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

4.70

10.66

4.7

3.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

310

2.35

10.65

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

779

6051

1.29

10.56

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

4.11

10.56

1.1

0.39

0.04

g/l

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1232

10096

1.23

10.54

3.6

535.26

2026.16

u/ml

1.48

1060

8706

(3002523) Influenza virus A Ag [Presence] in Specimen

779

6054

1.29

10.53

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

474

6457

0.73

10.37

1.4

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

916

11420

0.80

10.31

3.5

1.6

7.32

4.04

mg/l

5.63

767

8418

(3005033) Fetal Nuchal fold Thickness US

466

6351

0.73

10.23

1.4

1.5

1.23

1.26

0.74

317

4626

(3026051) Granulocytes/Leukocytes in Pleural fluid

101

498

2.03

10.20

1.3

1.4

32.21

22.00

2.35

422

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

4.09

10.10

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

200

1221

1.64

10.05

1.2

1.1

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

4.31

10.00

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3969

35798

1.12

9.95

1.5

—

7.64

—

(3035320) C reactive protein [Mass/volume] in Body fluid

335

2300

1.46

9.91

3.2

2.6

30.23

27.48

mg/l

0.67

264

1628

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

167

2.81

9.88

1.2

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

160

925

1.73

9.87

1.2

1.3

28.55

20.30

0.63

151

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

201

2.64

9.84

1.5

2.1

184.79

177.65

ug/g

0.09

176

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

352

2443

1.44

9.84

1.3

1.39

1.98

u/ml

0.77

200

1425

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

249

2.45

9.74

1.2

0.25

0.39

u/ml

0.29

(3010015) Selenium [Moles/volume] in Serum or Plasma

336

2.23

9.71

1.9

2.1

1.25

1.31

umol/l

0.90

243

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

28304

278486

1.12

9.70

5.0

4.9

1.49

1.47

mmol/l

24.69

26747

261750

(3023383) Lactate [Moles/volume] in Pleural fluid

126

682

1.85

9.70

1.3

3.87

3.41

mmol/l

0.71

116

633

(3043238) Trisomy 21 risk [Likelihood] in Fetus

493

6596

0.74

9.61

1.5

1.6

—

(4212803) Bone marrow aspirate examination

193

2.64

9.52

1.0

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

212

1334

1.59

9.45

2.5

2.3

27.73

35.13

umol/l

0.23

129

(3026470) Cobalt [Mass/volume] in Blood

220

1399

1.57

9.38

2.2

3.56

3.57

ug/l

0.01

200

1299

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.85

9.35

6.5

8.5

—

(3004775) Volume in Urine collected for unspecified duration

284

1913

1.49

9.29

2.5

2.3

754.74

663.75

2.69

209

1339

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

643

8252

0.77

9.26

1.5

67.54

61.92

ug/l

1.03

508

6852

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

179

2.68

9.23

1.2

1.0

—

(3003694) ABO and Rh group [Type] in Blood

9139

86091

1.08

9.22

1.5

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.53

9.17

1.0

1.1

1.18

1.33

u/field

0.15

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

233

2.45

9.11

1.1

81.96

93.53

titre

0.78

233

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

584

4457

1.31

9.10

1.1

3.76

3.03

eliau/ml

0.37

205

2195

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

229

2.44

8.95

1.3

1.41

1.56

ml/s/173m2

0.17

157

(3044242) Glucose [Moles/volume] in Arterial blood

217

1394

1.56

8.88

2.1

2.0

7.86

8.08

mmol/l

0.39

217

1394

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

146

851

1.72

8.80

1.5

1.7

—

161.67

iu/ml

—

(3025577) Chromium [Mass/volume] in Blood

212

1362

1.56

8.68

2.2

2.21

2.39

ug/l

0.33

175

1131

(3044416) Complement C4 [Mass/volume] in Pleural fluid

109

3.12

8.59

1.1

1.2

0.07

0.08

g/l

0.38

(46236302) HLA-C [Type] by High resolution typing

109

3.12

8.59

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

298

2065

1.45

8.47

2.0

1.9

1.78

2.98

u/field

0.53

164

1165

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

290

4129

0.70

8.39

1.2

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

160

2.69

8.34

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.45

8.32

1.1

4.64

4.99

mmol/l

0.24

(40768795) Lymph node Pathology biopsy report

395

2890

1.37

8.23

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

388

2.04

8.16

1.3

1.2

0.91

1.46

mmol/l

0.65

253

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

145

2.76

8.16

1.0

1.2

1.19

1.17

u/field

0.03

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

118

2.96

8.14

1.1

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

586

4548

1.29

8.12

3.3

0.81

0.80

nmol/l

0.15

457

3665

(40763590) HLA-DQ beta [Type]

108

3.05

8.07

1.0

—

(3017400) Magnesium [Moles/volume] in Urine

3.75

8.03

1.1

3.30

3.12

mmol/l

0.13

(40760410) HLA-B [Type] by High resolution

109

3.03

7.95

1.0

—

(40760409) HLA-A [Type] by High resolution

109

3.03

7.95

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

3.83

7.93

1.2

1.1

278.17

249.18

u/ml

0.30

(4198724) Urine methamphetamine measurement

1602

0.53

7.91

2.3

2.4

—

(3006969) Lambda light chains [Mass/volume] in Urine

3.69

7.86

1.1

0.29

0.03

g/l

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

230

1540

1.49

7.83

1.5

1.2

237.14

341.54

u/l

1.65

214

1432

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

111

2.97

7.72

1.3

1.0

0.05

0.45

mg/l

0.50

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

312

2.11

7.58

1.2

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

148

2.63

7.33

1.3

1.1

—

(3008295) Osmolality of Serum or Plasma

412

3094

1.33

7.30

1.4

1.5

277.20

279.84

mosm/kgh2o

1.55

326

2367

(3020650) Glucose [Presence] in Urine

162

1021

1.59

7.30

1.9

1.6

0.03

0.05

estimate

0.38

162

1021

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

229

1558

1.47

7.25

1.7

2.0

179.51

142.29

7.09

215

1475

(3013862) HLA-DP [Type]

111

2.88

7.12

1.0

—

(40762365) Oxygen content in Arterial blood by calculation

396

1.94

7.06

3.4

3.0

15.13

14.82

ml/dl

0.34

368

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

175

2.46

7.02

1.3

1.7

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.35

6.93

1.2

1.5

0.70

0.61

u/field

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

574

7162

0.80

6.66

1.5

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

26941

265278

1.08

6.64

4.4

4.2

1.29

mmol/l

0.01

25317

247289

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

336

1.99

6.62

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

469

1.83

6.62

1.2

1.75

1.67

mmol/l

0.17

290

(40758047) Lysozyme [Mass/volume] in Pleural fluid

205

2.29

6.61

1.1

1.2

10.81

10.39

mg/l

0.10

188

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

315

2308

1.37

6.61

1.1

20.64

18.66

u/ml

0.38

956

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

355

2654

1.34

6.54

2.3

2.5

21.01

19.19

nmol/l

2.17

337

2522

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

12794

123061

1.06

6.53

2.0

1.9

1.38

1.37

mmol/l

0.63

11000

104353

(3001019) Free T4 and TSH panel - Serum or Plasma

1421

16292

0.87

6.50

1.7

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

332

1.99

6.48

1.2

1.3

517.43

174.91

u/l

0.31

240

(3027570) Oxalate [Moles/time] in 24 hour Urine

176

2.38

6.47

1.4

1.5

287.93

315.55

umol/24h

0.38

176

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

873

7279

1.20

6.43

1.2

1.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.96

6.34

1.0

—

(3033086) Enterovirus Ab [Titer] in Serum

3.08

6.28

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.44

6.25

1.0

1.1

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

+∞

6.25

4.0

0.0

—

(3006270) Folate [Moles/volume] in Blood

280

2035

1.38

6.21

1.2

1.1

353.02

374.33

nmol/l

1.01

247

1754

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

282

2056

1.37

6.14

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

137

870

1.57

6.06

1.3

125.63

129.41

nmol/l

0.10

101

629

(3024666) Lithium [Moles/volume] in Serum or Plasma

126

1967

0.64

5.97

12.1

13.4

0.62

mmol/l

0.08

111

1827

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

420

1.83

5.97

1.3

35.95

42.65

mg/l

0.78

353

(3011985) Renin [Units/volume] in Plasma

562

4517

1.25

5.96

1.6

70.96

65.64

mu/l

0.23

508

4061

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

172

1153

1.49

5.95

1.2

0.31

0.30

g/l

1.36

146

922

(4281824) Cell count and differential, peritoneal fluid

246

3380

0.72

5.91

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

27331

269528

1.08

5.86

5.0

5.80

5.89

mmol/l

26.89

25583

250694

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

186

1273

1.46

5.81

1.1

95.11

97.89

0.57

151

1007

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

155

1023

1.52

5.79

1.1

97.13

89.93

1.47

480

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

3.23

5.69

5.3

5.5

8.68

4.99

mg/l

0.49

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

108

659

1.64

5.66

1.3

1.2

316.45

286.06

ug/l

0.04

356

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

160

1071

1.49

5.61

1.1

1.2

116.05

107.77

1.56

150

973

(3005082) Progesterone [Moles/volume] in Serum or Plasma

111

1754

0.63

5.59

1.4

31.67

34.32

nmol/l

0.42

100

1597

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

283

1.98

5.49

4.1

2.8

1.85

1.21

mg/l

0.58

199

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

156

1044

1.49

5.48

1.1

94.47

90.05

0.99

481

(3012494) Peanut IgE Ab [Units/volume] in Serum

136

884

1.54

5.48

1.1

2.54

6.78

u/ml

0.57

531

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1181

10252

1.16

5.42

1.5

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

198

2.17

5.39

1.0

1.1

50.47

9.98

iu/ml

1.67

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3104

28527

1.10

5.36

3.6

4.3

18.67

26.34

ug/l

0.86

2436

22885

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

225

2.09

5.34

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

514

4146

1.24

5.33

1.4

335.86

384.11

pmol/l

0.65

446

3579

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2243

20294

1.11

5.32

3.2

3.5

4.46

4.52

pmol/l

1.27

2050

18321

(3041184) Isoniazid [Presence] in Urine

5.38

5.20

2.6

2.8

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

165

1135

1.45

5.09

1.8

2.1

201.94

162.33

3.74

157

1079

(44813793) Dust mix specific IgE antibody measurement

303

2304

1.32

5.08

1.0

1.1

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

3.00

5.07

1.1

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

245

2.00

4.98

1.3

1.4

57.96

73.04

2.19

208

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

986

8510

1.16

4.93

2.0

1.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

156

2237

0.69

4.91

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

3.57

4.74

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

243

1.97

4.74

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

7.13

4.64

1.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

4.28

4.61

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

603

1.59

4.56

2.0

2.8

1201.39

262.39

ug/l

0.41

603

(3009214) Lutropin [Units/volume] in Serum or Plasma

1123

9845

1.14

4.55

1.6

1.4

10.92

10.20

u/l

0.92

923

7885

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

9.99

4.51

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

150

1040

1.44

4.49

1.5

1.4

14.79

14.72

pmol/l

0.06

128

876

(3021691) Plasmodium malariae Ab [Titer] in Serum

4.81

4.48

2.2

2.6

—

(3011288) Drugs identified in Urine by Screen method Nominal

887

10214

0.86

4.42

2.3

3.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

105

681

1.54

4.37

1.1

1.2

84.75

87.24

0.19

186

(3000919) Neutrophils/Leukocytes in Pleural fluid

588

1.58

4.33

1.5

1.4

34.50

20.16

3.95

544

(40768800) Prostate Pathology biopsy report

370

4599

0.80

4.31

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1006

8791

1.15

4.29

2.2

2.0

4.90

10.59

iu/l

1.13

390

3684

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

164

2.13

4.27

1.1

1.93

3.27

u/l

0.74

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

536

1.60

4.25

1.7

1.46

1.20

nmol/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

443

5390

0.82

4.22

1.5

61.05

60.08

ug/l

0.18

443

5390

(43055442) Apixaban [Mass/volume] in Serum or Plasma

403

1.69

4.10

1.5

1.6

124.98

108.91

ug/l

0.60

336

(3012898) Urea [Moles/volume] in Urine

293

1.81

4.07

1.2

1.5

184.51

170.52

mmol/l

0.31

266

(3006462) Nitrate [Presence] in Urine

174

1264

1.38

4.04

5.2

2.7

—

(3002079) Sodium [Moles/time] in 24 hour Urine

197

1462

1.35

4.00

1.3

1.2

154.44

161.01

mmol/24h

0.58

197

1462

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

196

1454

1.35

3.99

1.6

2.2

117.31

136.78

umol/l

0.32

106

702

(3001893) Eosinophils/Leukocytes in Pleural fluid

648

1.53

3.99

1.5

1.4

4.34

2.73

0.72

562

(3014271) Vancomycin [Susceptibility]

150

1069

1.40

3.92

2.8

2.9

—

(3033942) Copper [Moles/time] in 24 hour Urine

131

2.21

3.89

1.1

1.3

0.32

0.80

umol/24h

1.14

(3005532) Lymphocytes/Leukocytes in Pleural fluid

114

773

1.47

3.89

1.5

1.4

49.66

64.20

3.65

650

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

150

2068

0.72

3.85

1.6

1.5

—

(4211845) Urine protein measurement

187

1387

1.35

3.83

5.0

2.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

151

1082

1.40

3.83

1.2

111.21

110.60

0.10

132

977

(3018291) Platelet Ab [Presence] in Serum

3.68

3.78

1.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

421

1.64

3.76

1.1

1.0

0.05

0.36

u/ml

1.64

272

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

422

0.40

3.72

1.2

—

(3025130) Human papilloma virus identified in Specimen

605

5155

1.18

3.67

2.1

1.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.42

3.61

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

225

1.87

3.60

1.0

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

211

1.89

3.59

1.3

1.4

15.89

16.01

pmol/l

0.02

184

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.71

3.58

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.71

3.58

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.71

3.58

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.71

3.58

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.71

3.58

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.71

3.58

1.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

401

3302

1.22

3.57

1.2

53.50

33.48

nmol/l

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

4.76

3.54

8.1

2.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

105

721

1.46

3.41

7.5

8.0

5.93

5.96

kpa

0.10

654

(3028468) Fragments [Presence] in Blood by Light microscopy

5.71

3.33

1.0

2.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

329

1.67

3.28

2.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

120

856

1.40

3.20

5.8

6.6

24.21

25.13

mmol/l

2.16

108

785

(3000034) Microalbumin [Mass/volume] in Urine

285

2295

1.24

3.19

3.1

3.0

49.64

48.84

mg/l

0.02

226

1617

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

371

1.62

3.17

1.3

1.4

56.50

52.63

0.26

185

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

685

1.44

3.13

1.1

68.04

75.73

0.77

181

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

101

1430

0.70

3.13

1.1

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

186

1.88

3.12

1.1

1.2

23.23

20.69

0.12

(3020123) Porphyrins [Interpretation] in Serum or Plasma

180

1.89

3.07

1.0

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

522

4470

1.17

3.05

1.3

0.22

0.26

nmol/l

0.31

279

(3027874) Urate [Moles/volume] in Urine

2.22

3.04

1.1

1.56

1.88

mmol/l

0.50

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

498

1.51

2.93

5.1

2.3

1.20

1.19

mmol/l

0.69

479

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1304

11867

1.10

2.91

1.5

1.6

16.18

16.63

u/ml

0.07

219

2981

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

512

4403

1.16

2.86

1.3

0.61

1.68

nmol/l

1.31

494

4251

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

352

2935

1.20

2.84

1.4

1.3

1.60

1.45

nmol/l

1.72

318

2648

(3027231) Wheat IgE Ab [Units/volume] in Serum

691

1.42

2.84

1.1

1.49

2.95

u/ml

0.57

598

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

154

1168

1.32

2.83

1.9

—

(40762814) Titanium [Mass/volume] in Blood

399

1.55

2.81

2.5

2.6

3.89

3.68

ug/l

0.15

144

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1237

11250

1.10

2.81

1.6

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

653

1.42

2.76

7.5

7.9

6.32

5.57

kpa

1.02

653

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2408

22539

1.07

2.74

1.2

120.18

141.52

u/ml

2.04

862

8533

(40760512) CD34 cells/cells in Bone marrow

4.99

2.72

1.6

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

688

6071

1.13

2.69

2.8

2.4

81.78

108.97

ug/min

1.67

389

3659

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

439

3752

1.17

2.68

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

404

1.53

2.68

1.3

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

236

1906

1.24

2.65

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

273

1.65

2.62

1.1

1.0

0.06

0.04

u/ml

0.44

273

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

162

1.85

2.59

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1054

0.69

2.59

2.5

3.1

28.31

28.44

umol/l

0.04

803

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

157

2013

0.78

2.56

1.8

2.1

—

(3008037) Lactate [Moles/volume] in Venous blood

707

6275

1.13

2.54

3.6

3.1

1.43

1.55

mmol/l

4.69

683

6127

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

101

2.08

2.51

1.1

1.3

1.18

1.12

u/field

0.05

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

577

1.42

2.45

1.3

1.18

mmol/l

0.19

577

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

145

1116

1.30

2.45

2.3

2.7

1.37

1.13

ug/l

0.70

137

1060

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

144

1.87

2.44

1.1

1.0

—

(3026657) Rickettsia conorii Ab [Titer] in Serum

2.55

2.43

1.1

—

371.20

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.12

2.42

1.0

1.2

1.60

1.28

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

203

1.72

2.42

5.0

3.5

11.39

9.55

0.16

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

440

3807

1.16

2.35

1.2

1.3

0.19

0.21

nmol/l

1.06

344

2959

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

132

1.89

2.34

1.2

1.6

0.17

0.03

u/l

0.35

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

183

1.75

2.33

1.0

22.09

17.36

u/ml

0.22

152

(3027974) Hepatitis B virus e Ag [Presence] in Serum

200

1.70

2.26

1.1

1.6

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

113

1.94

2.23

1.0

1.2

250.41

306.70

nmol/l

0.71

113

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1567

16798

0.93

2.22

2.5

3.6

44.26

53.78

u/ml

1.03

1504

16255

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.19

1.3

1.8

73.33

131.36

ug/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

344

4004

0.86

2.19

1.4

1.3

7.30

7.11

mmol/l

0.55

316

3547

(3013945) Hepatitis B virus e Ab [Presence] in Serum

187

1.71

2.18

1.1

1.6

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.24

2.16

1.1

1.2

32.13

32.76

mg/24h

0.06

(3008116) Ketones [Moles/volume] in Urine by Test strip

677

1.36

2.16

1.4

1.5

0.31

0.34

mmol/l

0.09

117

(40765089) Chromosome analysis panel - Blood by G-banded

1058

0.73

2.12

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

182

1.70

2.09

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

487

1.42

2.08

1.0

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

124

1.85

2.05

1.0

0.25

0.07

u/ml

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

290

2463

1.18

2.02

1.1

9.08

8.00

iu/ml

0.20

663

(3001218) Citrate [Mass/time] in 24 hour Urine

2.35

1.94

1.9

1.4

299.58

430.73

mg/24h

1.56

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

179

1.67

1.93

6.1

5.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

297

1.51

1.92

1.1

1.0

32.51

0.50

u/ml

0.52

147

(3020874) Milk IgE Ab [Units/volume] in Serum

258

2182

1.18

1.91

1.1

7.26

2.19

u/ml

0.49

106

740

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.00

1.89

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

196

1.63

1.88

1.0

1.1

13.59

8.24

u/l

0.28

196

(3005570) Glucose [Moles/volume] in Urine

313

2696

1.16

1.85

2.1

1.9

1.10

25.77

mmol/l

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

4.16

1.82

1.0

23.60

21.75

umol/l

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.16

1.82

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

4.16

1.82

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4357

45095

0.96

1.81

3.0

3.1

0.70

0.75

ug/l

2.21

2843

28132

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3998

38442

1.04

1.81

1.6

1.8

1.50

1.44

6.18

3472

34125

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

3.04

1.79

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

470

1.38

1.76

1.0

1.1

5.28

10.20

u/ml

1.34

470

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

142

1146

1.24

1.73

2.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

147

1.70

1.72

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.66

1.72

1.1

1.0

0.38

0.07

u/ml

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

140

1.71

1.70

1.0

0.23

0.12

u/ml

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

340

1.44

1.68

1.0

0.76

0.20

u/ml

1.14

215

(3012989) Citrate [Moles/time] in 24 hour Urine

2.18

1.66

1.7

1.4

1.98

2.01

mmol/24h

0.03

(3032641) Amino acids panel - Urine

2.50

1.66

1.3

1.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

2.80

1.64

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

522

5782

0.90

1.63

4.3

3.3

28.63

26.42

mg/l

0.79

376

3935

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

378

0.61

1.62

2.2

3.6

39.17

40.97

umol/l

0.15

325

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

113

1.77

1.59

1.2

1.1

2698.90

3878.73

ng/l

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

471

1.36

1.59

7.0

6.9

10.75

10.58

0.21

471

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

393

4408

0.89

1.55

1.4

2.92

3.76

ug/l

1.94

357

3876

(3018001) Oat IgE Ab [Units/volume] in Serum

231

1.51

1.55

1.1

1.0

2.89

0.24

u/ml

0.57

133

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

752

1.28

1.54

2.5

3.0

100.96

112.38

ng/l

0.43

406

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

388

3445

1.13

1.53

1.0

1.1

—

(3007733) Chloride [Moles/volume] in Urine

1.92

1.53

1.4

1.6

101.07

81.49

mmol/l

0.69

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.92

1.53

1.4

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

245

2113

1.16

1.50

1.1

4.24

4.42

u/ml

0.03

562

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7683

75022

1.03

1.48

4.7

5.3

2.25

2.83

ug/l

2.83

6972

68455

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

161

1917

0.84

1.46

1.0

341.34

330.18

ng/l

0.15

123

1399

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

249

2155

1.16

1.46

1.2

1.5

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

24458

242509

1.03

1.46

39.9

18.1

331.12

332.64

g/l

129.89

24384

241224

(4146454) Self-monitoring of blood glucose

259

2969

0.87

1.46

2.8

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

787

0.75

1.44

6.5

6.6

10.25

8.80

0.85

787

(40761995) Spermatozoa Progressive [#/volume] in Semen

787

0.75

1.44

3.2

3.3

39.93

44.69

1.06

787

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

567

0.70

1.43

1.4

1.2

71.98

69.14

ug/l

0.13

567

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

188

1.54

1.41

1.0

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1031

11002

0.93

1.40

1.6

1.8

—

22.16

—

(44806420) Estimation of glomerular filtration rate

388

3469

1.12

1.39

2.7

2.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

663

6095

1.09

1.36

1.4

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

236

0.55

1.36

1.1

0.98

1.22

mom

1.67

236

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

176

1492

1.18

1.36

3.0

6.7

3878.25

2874.08

u/ml

—

287

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.61

1.36

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

206

1.50

1.36

1.6

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

109

888

1.23

1.30

2.8

3.3

4.87

4.94

kpa

0.28

109

888

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

109

889

1.23

1.29

2.8

3.3

11.19

10.44

kpa

1.08

109

889

(3014178) Parietal cell Ab [Units/volume] in Serum

2.40

1.24

1.2

1.1

64.33

48.16

u/ml

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.85

1.23

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

165

1925

0.86

1.23

1.0

40.42

41.14

ng/l

0.08

122

1381

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

165

1922

0.86

1.21

1.0

814.98

750.03

ng/l

0.99

123

1353

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

431

0.69

1.20

1.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

191

2197

0.87

1.19

1.3

151.31

189.50

pmol/l

2.05

191

2197

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

156

1.54

1.19

8.4

11.0

105.58

104.74

g/l

0.13

156

(3013336) Amino acids [Identifier] in Serum or Plasma

109

1.65

1.17

1.6

3.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

153

1302

1.17

2.1

2.6

36.94

53.20

umol/l

6.47

133

1142

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

173

1.50

1.16

2.7

2.2

7.60

20.74

3.51

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

325

1.35

1.14

1.6

1.4

12.56

13.92

0.14

170

(3036312) Salmon IgE Ab [Units/volume] in Serum

199

1.46

1.13

1.0

1.1

1.02

1.74

u/ml

0.30

146

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

669

7180

0.93

1.13

1.4

128.58

138.86

pmol/l

0.19

648

7012

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.68

1.13

1.1

1.0

7.15

0.22

u/ml

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.33

1.12

1.1

1.3

—

(44786800) Granulocytes/Leukocytes in Body fluid

258

1.39

1.12

1.3

35.81

22.97

1.22

198

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

159

1.51

1.10

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.70

1.10

1.0

4.42

14.11

mg/l

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

217

1.43

1.10

1.3

1.2

91.45

103.48

ug/l

0.25

133

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

234

2070

1.13

1.08

2.3

3.5

181.50

142.96

nmol/l

0.40

222

2046

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

210

1.43

1.07

1.4

1.5

32.70

37.26

0.24

141

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

567

1.25

1.06

1.2

115.27

56.90

mg/l

0.29

395

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

295

1.35

1.06

1.1

0.71

1.26

u/ml

0.37

217

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

219

1.41

1.05

2.7

2.2

57.95

59.33

0.07

133

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

416

3809

1.09

1.02

1.5

1.7

357.63

376.19

mu/l

0.27

350

3071

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

110

0.45

0.99

1.8

2.1

277.00

242.98

ug/l

—

110

(43055514) Macroprolactin [Presence] in Serum or Plasma

862

0.81

0.99

1.5

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

132

1132

1.17

0.97

1.4

192.36

196.20

nmol/24h

0.01

132

1132

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

250

1.36

0.94

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

191

1687

1.13

0.94

1.5

1.6

1.44

1.26

nmol/l

1.02

141

1281

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.89

0.94

1.0

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

2.22

0.93

1.0

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

109

1.56

0.92

1.1

1.0

0.09

0.04

u/ml

0.62

109

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

175

1540

1.14

0.91

3.1

2.0

199.11

200.44

u/l

0.09

175

1529

(3003577) Lead [Moles/volume] in Blood

279

0.68

0.90

1.8

1.4

0.22

0.26

umol/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

488

5243

0.93

0.90

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

140

1601

0.87

0.88

1.4

5.45

5.69

mmol/l

1.67

129

1509

(3002331) Protein [Mass/volume] in Peritoneal fluid

638

1.21

0.86

1.3

1.4

23.11

56.51

g/l

0.63

490

(4094501) Cardiovascular stress test using bicycle ergometer

781

8233

0.95

0.83

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

162

1431

1.13

0.82

1.5

1.8

2.77

3.14

u/ml

0.11

412

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

313

2865

1.09

0.82

4.5

5.3

126.26

101.26

u/ml

0.22

107

966

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

651

1.20

0.82

1.2

425.98

299.44

pmol/l

0.71

484

(3026692) Albumin [Mass/volume] in Peritoneal fluid

725

1.19

0.81

1.5

1.4

11.34

13.62

g/l

1.50

553

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

524

4902

1.07

0.80

1.1

49.35

2786.47

iu/ml

0.67

116

1014

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

562

1.21

0.80

1.2

2.0

2.67

2.73

ug/l

0.03

349

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

134

1173

1.14

0.79

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

124

1080

1.15

0.79

1.0

0.53

0.69

u/ml

0.35

118

1064

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

321

1.28

0.78

2.8

2.3

0.78

0.61

u/field

0.45

321

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

123

0.57

0.77

1.4

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

621

1.19

0.75

1.1

1.2

3.18

5.97

u/ml

0.70

415

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

496

1.21

0.72

2.2

2.3

8.09

7.47

mmol/l

0.25

290

(3014891) Appearance of Pleural fluid

272

1.29

0.71

1.4

1.6

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

110

0.54

0.71

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

151

1.39

0.70

1.5

606.18

480.65

nmol/l

0.43

151

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

282

1.28

0.70

1.4

1.3

13.50

15.66

nmol/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

628

5942

1.06

0.69

3.1

2.1

1.01

0.85

nmol/l

4.97

546

5050

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

1.85

0.68

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

647

1.17

0.68

1.2

1.3

5.66

2.04

u/ml

0.31

640

(3016273) Islet cell 512 Ab [Units/volume] in Serum

222

1.30

0.67

1.1

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

1109

0.87

0.66

1.8

1.4

0.53

0.51

e9/l

0.24

1109

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

141

1572

0.90

0.65

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5912

59908

0.98

0.62

4.0

4.3

21.77

21.96

0.41

2808

27800

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

405

1.21

0.62

2.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.57

0.60

1.3

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

466

0.81

0.60

1.0

81.61

81.35

ug/l

0.01

364

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

112

1257

0.89

0.59

2.0

2.1

54.54

117.97

ug/min

1.17

272

(3019298) Eosinophils/Leukocytes in Peritoneal fluid

1.54

0.59

1.3

1.4

0.43

0.40

—

(3016031) Almond IgE Ab [Units/volume] in Serum

254

1.26

0.58

1.1

1.0

0.55

1.00

u/ml

0.54

149

(3006598) pH of Arterial cord blood

185

0.70

0.58

1.1

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

133

1.35

0.54

5.7

9.7

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.50

0.54

1.3

2.4

1.78

3.43

mu/l

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

193

0.72

0.53

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1094

0.89

0.50

1.0

7.75

10.10

u/ml

0.68

701

(3015076) Soybean IgE Ab [Units/volume] in Serum

208

1925

1.08

0.50

1.1

0.48

1.06

u/ml

0.90

484

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

202

2173

0.93

0.48

1.6

7.81

7.77

mmol/l

0.08

194

2087

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

244

1.23

0.47

1.0

1.1

0.20

0.22

u/ml

0.07

244

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

355

1.18

0.46

1.1

1.0

0.12

1.85

u/ml

0.84

168

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

243

0.78

0.46

1.9

3.2

4675.00

57.04

pmol/l

—

(3028717) Thiamine [Mass/volume] in Blood

420

1.17

0.46

1.1

1.2

64.59

63.19

ug/l

0.12

420

(3010370) Gastrin [Moles/volume] in Serum or Plasma

495

1.15

0.45

1.3

1.9

63.47

58.19

pmol/l

0.09

419

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3425

33670

1.02

0.44

4.5

4.9

33.46

32.17

9.41

2557

22973

(4038314) Semen analysis, post vasectomy

241

0.79

0.43

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1742

17020

1.02

0.42

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

725

1.12

0.42

2.1

1.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

424

1.15

0.42

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

424

1.15

0.42

1.1

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.41

0.0

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

351

1.17

0.40

1.1

0.07

0.82

u/ml

1.38

170

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.33

0.40

1.0

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

346

0.84

0.39

1.2

6.12

5.86

mmol/l

0.28

346

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

517

0.87

0.39

1.3

1.6

4.98

5.40

nmol/l

0.19

497

(3051101) Glucose [Moles/volume] in Cord blood

399

0.85

0.39

3.6

5.7

9.79

8.34

mmol/l

0.50

399

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

258

0.81

0.38

1.3

1.2

45.85

47.78

mg/l

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

142

1.27

0.38

1.1

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

301

0.83

0.38

1.4

1.2

21.07

20.79

mmol/l

0.11

245

(3029396) Erythrocyte agglutination [Presence] in Blood

883

0.90

0.37

3.0

2.9

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

326

1.16

0.37

1.1

0.51

1.00

u/ml

0.32

156

(3022475) Manganese [Moles/volume] in Blood

191

0.78

0.37

1.4

1.3

0.16

umol/l

0.32

191

(3041354) Potassium [Moles/volume] in Venous blood

289

2745

1.05

0.36

2.9

2.3

4.05

4.04

mmol/l

0.17

284

2725

(4133840) Spirometry

810

1.10

0.36

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

190

0.79

0.35

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1940

19032

1.02

0.35

1.9

2.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

583

5632

1.03

0.34

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

528

5459

0.97

0.34

1.5

0.36

0.38

nmol/l

0.19

399

4161

(3013139) Helicobacter pylori Ag [Presence] in Stool

2109

21400

0.98

0.32

1.2

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

130

1391

0.93

0.32

1.1

11.92

9.03

u/ml

0.22

244

(3033923) Metanephrine [Moles/time] in 24 hour Urine

587

1.11

0.32

1.1

0.67

0.80

umol/24h

0.52

291

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

587

1.11

0.32

2.1

1.6

0.19

0.22

nmol/l

0.52

430

(3023323) Follitropin [Units/volume] in Serum or Plasma

1816

17828

1.02

0.32

1.5

1.4

27.51

27.09

iu/l

0.20

1553

15225

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

229

1.18

0.31

1.0

1.1

20.97

6.41

u/ml

0.70

141

(3035285) Chloride [Moles/volume] in Venous blood

287

2744

1.04

0.30

2.9

2.3

105.54

105.61

mmol/l

0.09

282

2724

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

343

3293

1.04

0.30

2.5

3.5

22.68

7.47

nmol/l

0.45

330

3186

(3038515) Glucose [Moles/volume] in Venous blood

535

5181

1.03

0.29

4.0

3.2

7.17

7.50

mmol/l

2.07

517

5062

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2419

24488

0.99

0.29

2.4

2.3

13.11

13.00

nmol/l

0.26

2209

22328

(3020491) Glucose [Moles/volume] in Blood

219

2084

1.05

0.28

1.8

1.7

6.73

6.71

mmol/l

0.05

172

1521

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

110

0.73

0.28

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

139

1.22

0.28

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

354

1.13

0.28

1.1

1.48

3.07

u/ml

0.72

274

(3020191) Ethanol [Moles/volume] in Serum or Plasma

254

2650

0.96

0.28

1.3

1.5

1.03

1.31

promille

2.55

199

2075

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

386

0.88

0.28

2.0

2.9

65.31

76.80

pmol/l

0.31

335

(3049233) Organic acids panel - Urine

1.29

0.28

1.1

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

207

1970

1.05

0.27

1.3

3.89

5.01

umol/l

4.89

184

1733

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.25

0.27

1.0

1.1

2.25

2.81

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

172

1808

0.95

0.26

1.9

1.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

525

5391

0.97

0.26

1.1

4.89

4.06

u/ml

0.41

259

2740

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

443

1.10

0.25

1.9

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

424

1.11

0.25

1.1

—

(3034614) HLA Ag [Interpretation]

1.20

0.25

1.1

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

444

1.10

0.24

2.0

2.3

1.42

1.29

mmol/l

0.12

300

(3040794) Aluminum [Moles/volume] in Urine

1.31

0.23

1.2

1.3

0.66

0.38

umol/l

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.77

0.22

1.1

19.85

46.65

umol/24h

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

210

0.86

0.22

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

135

0.81

0.22

1.0

1.1

0.01

1.49

u/ml

1.86

135

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

168

1604

1.05

0.22

1.4

2.0

735.53

572.73

pmol/l

0.10

250

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

191

1830

1.04

0.21

6.3

7.3

135.39

54.80

ug/l

0.51

129

1176

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

709

0.93

0.21

1.0

1.1

30.00

29.03

iu/ml

0.06

709

(3013931) Oligosaccharides [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

155

1.16

0.19

1.1

1.0

66.81

0.38

u/ml

0.48

(37021550) Renin [Units/volume] in Plasma --upright

577

1.07

0.19

1.2

1.3

193.53

75.64

mu/l

0.40

437

(1761482) Bacteria [#/volume] in Urine by Culture

617

6040

1.02

0.19

4.6

4.0

—

(3029612) Listeria sp Ab [Titer] in Serum

1.13

0.18

1.0

1.4

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

492

1.08

0.18

3.0

2.8

6620.31

1263.48

u/l

1.01

441

(3000285) Sodium [Moles/volume] in Blood

492

1.08

0.18

1.2

137.94

138.26

mmol/l

0.23

405

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

759

7453

1.02

0.17

1.1

2.41

2.07

u/ml

0.30

398

4030

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

223

1.12

0.17

1.0

5.51

1.62

u/ml

0.73

178

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.21

0.17

1.0

0.01

0.28

u/ml

—

(3044007) Cell count panel - Peritoneal fluid

882

1.05

0.17

2.2

1.9

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1181

11946

0.99

0.17

1.6

1.7

286.08

305.21

mu/l

1.51

1061

10846

(3033705) Calcium.ionized [Moles/volume] in Venous blood

278

2700

1.03

0.17

2.9

2.3

1.20

mmol/l

0.55

273

2680

(3022670) pH of Venous cord blood

0.75

0.17

1.2

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

618

0.94

0.16

1.6

2.0

—

(3036180) Methadone [Presence] in Urine

1.09

0.15

1.1

2.6

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.75

0.15

1.2

1.0

345.50

356.58

u/l

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

351

1.08

0.15

1.0

1.1

0.47

3.95

u/ml

2.85

271

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

521

5113

1.02

0.14

1.4

27.59

27.54

u/l

0.01

432

4180

(3023430) Cat dander IgE Ab [Units/volume] in Serum

500

5081

0.98

0.14

1.0

1.1

3.69

4.97

u/ml

1.32

222

2320

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

498

1.06

0.14

8.9

7.1

67.92

69.59

0.20

385

(40758358) Immune stain study

128

0.86

0.13

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.19

0.13

1.0

4.60

3.10

u/ml

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

989

9990

0.99

0.13

1.8

1.9

41.39

41.07

nmol/l

0.15

968

9776

(3017509) Phencyclidine [Presence] in Urine

376

0.93

0.13

1.8

1.9

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

293

0.92

0.12

1.0

1.1

1.89

1.72

umol/24h

0.34

293

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

344

3370

1.02

0.12

1.7

2.1

27.93

25.40

ug/l

0.23

334

3310

(3017958) Strawberry IgE Ab [Units/volume] in Serum

104

1.15

0.12

1.0

0.01

0.07

u/ml

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

753

7435

1.01

0.11

2.0

1.9

199.02

201.58

pmol/l

0.30

716

7101

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

434

0.94

0.11

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.16

0.10

1.0

1.1

—

mmol/l

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

278

2829

0.98

0.10

1.3

1.4

8.98

8.48

mmol/l

1.02

265

2687

(3003888) Timothy IgE Ab [Units/volume] in Serum

646

6525

0.99

0.10

1.1

4.95

5.07

u/ml

0.07

336

3539

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.14

0.10

1.0

1.1

151.00

222.77

pmol/l

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.04

0.09

1.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

155

1.10

0.08

2.2

3.9

—

0.00

estimate

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.07

0.08

2.0

2.1

24.75

29.83

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

620

6129

1.01

0.08

1.1

2.17

1.83

u/ml

0.35

339

3154

(3023487) Leukocytes [#/volume] in Peritoneal fluid

103

1057

0.97

0.08

2.3

2.0

376.18

2378.19

e6/l

1.53

706

(3032868) Hemoglobin electrophoresis panel in Blood

287

0.94

0.08

1.4

1.5

—

(46235168) Fasting glucose [Moles/volume] in Blood

348

0.95

0.08

1.3

2.0

5.49

7.32

mmol/l

—

105

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.77

0.08

1.0

176.00

163.11

g/l

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.08

0.08

1.0

1.5

2.25

2.05

g/l

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.13

0.08

1.0

—

(3042517) Benzodiazepines panel - Urine

438

0.96

0.07

2.3

2.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2283

22891

1.00

0.07

2.1

2.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

168

1.07

0.05

2.3

0.63

0.65

ug/l

0.11

168

(3008401) Mugwort IgE Ab [Units/volume] in Serum

630

6258

1.01

0.04

1.1

1.71

0.99

u/ml

0.97

283

2832

(3001556) Androgen free Index in Serum or Plasma

308

1.04

0.04

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

452

4537

0.99

0.03

1.0

1.1

0.63

0.39

u/ml

0.41

157

1437

(3018851) Theophylline [Moles/volume] in Serum or Plasma

231

1.04

0.02

1.6

1.8

41.54

48.78

umol/l

0.77

231

(3007463) Buprenorphine [Presence] in Urine

152

1.05

0.02

2.2

8.4

—

(3007542) Rye IgE Ab [Units/volume] in Serum

182

1.04

0.02

1.1

1.0

81.31

0.31

u/ml

0.48

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.07

0.02

1.0

1.2

314.80

359.49

pmol/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

154

1548

0.99

0.01

1.6

4.58

8.58

nmol/l

0.49

126

1285

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

901

1.01

0.01

2.4

1.9

5197.82

12292.74

e6/l

1.09

465

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

368

1.00

0.00

1.1

1.2

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

337

1.01

0.00

1.0

1.4

—

0.96

mmol/l

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

337

1.01

0.00

1.0

1.4

—

1.65

mmol/l

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

402

4009

1.00

0.00

1.5

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.41

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

0.96

-0.00

1.0

1.1

—

29.61

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3025311) HLA-B [Type]

0.00

-0.00

0.0

1.0

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.1

—

302.56

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

8.78

—

(3028050) Streptolysin O Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

148.17

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

10.0

—

(36305197) Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint RX_CROHN_2NDLINE and mortality.

Females

Parameter	HR [95% CI]	p-value
RX_CROHN_2NDLINE	1.489 [1.37, 1.62]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.426

During the follow-up period (1.1.1998 — 31.12.2019), 9945 out of 74466 females with RX_CROHN_2NDLINE died.

Males

Parameter	HR [95% CI]	p-value
RX_CROHN_2NDLINE	1.482 [1.35, 1.63]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 7804 out of 50876 males with RX_CROHN_2NDLINE died.

Mortality risk

Mortality risk for people of age

years, who have RX_CROHN_2NDLINE.

N-year risk	Females	Males
1	0.109%	0.213%
5	0.853%	1.45%
10	2.094%	3.974%
15	4.265%	7.84%
20	7.491%	13.469%

Relationships between endpoints

↥

Index endpoint: RX_CROHN_2NDLINE – Second line medication for Crohn's disease

GWS hits: 47

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Second line medication for Crohn's disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints